Obg practical examination preparation - give case sheet, presentation with "why" of every history and cause and differential diagnosis, summary with positive history and examination findings, examination procedure ,diagnosis with explanation, case discussion, investigation and management and possible viva questions and answers for the following obstetrics topics( refer hepsibah kirubamani practical obg book) Hypertensive disorders in pregnancy -preclampsia, eclampsia, gestational hypertension,Anemia complicating pregnancy, rh-ve pregnancy, diabetes complicating pregnancy, multiple pregnancy, malpresentation -breech, recurrent pregnancy loss, iugr/ fgr, heart disease complicating pregnancy, thyroid disorders in pregnancy, previous lscs, cpd, normal puerperium,postdated delivery. give these long cases one by one as I say next

Reading File

Understood! Here is a full overview of what I'll be preparing for you, and how we'll proceed:

OBG Practical Examination - Long Case Preparation Plan

I will prepare one complete long case at a time, and you say "next" to move to the next topic. Each case will follow this structured format:

Format for Each Long Case:

Case Sheet - Proforma with history, examination, investigation fields
Presentation with "WHY" - Every history question with the reason/rationale for asking it
Causes & Differential Diagnosis - With explanations
Summary - Positive history + positive examination findings
Examination Procedure - Step-by-step clinical examination
Diagnosis with Explanation - How you arrive at the diagnosis
Case Discussion - Pathophysiology, clinical significance
Investigations & Management - Detailed plan
Possible Viva Questions & Answers - Examiner-style Q&A

Topics Lineup (in order):

#	Topic
1	Hypertensive Disorders in Pregnancy (Pre-eclampsia, Eclampsia, Gestational Hypertension)
2	Anemia complicating pregnancy
3	Rh-negative pregnancy
4	Diabetes complicating pregnancy
5	Multiple pregnancy
6	Malpresentation - Breech
7	Recurrent pregnancy loss
8	IUGR / FGR
9	Heart disease complicating pregnancy
10	Thyroid disorders in pregnancy
11	Previous LSCS
12	CPD
13	Normal puerperium
14	Postdated delivery

LONG CASE 1: HYPERTENSIVE DISORDERS IN PREGNANCY

(Pre-eclampsia / Eclampsia / Gestational Hypertension)

PART 1 - CASE SHEET (PROFORMA)

OBSTETRIC CASE SHEET

Date: _____________ IP No: _____________ Ward: _____________

A. PERSONAL DETAILS


Name
Age
Gravida / Para / Living / Abortion	G P L A
Address
Occupation (Patient)
Occupation (Husband)
Socioeconomic status
Education
Religion

B. CHIEF COMPLAINTS

Swelling of feet / legs / face since _____ days/weeks
Headache since _____
Blurring of vision since _____
Epigastric / right hypochondriac pain since _____
Convulsions (if eclampsia) - number, type, timing
Decreased urine output since _____
No fetal movements since _____

C. HISTORY OF PRESENT ILLNESS

Onset: Gradual / Sudden
Duration
Progression
Aggravating / Relieving factors
Associated symptoms: headache, visual disturbances, epigastric pain, oliguria, decreased fetal movements

D. OBSTETRIC HISTORY

Present Pregnancy:

LMP: _________ EDD: _________
POG: _____ weeks _____ days
Booking: Booked / Unbooked
ANC visits: _____ times
Any USG done - dating scan / anomaly scan / growth scan
Quickening felt at _____ weeks
Fetal movements currently: Present / Absent / Decreased

Previous Obstetric History:

Pregnancy	Year	Gestational age	Mode of delivery	Sex	Birth weight	Outcome	Complications
1
2

E. MENSTRUAL HISTORY

Age of menarche: _____
Cycle: Regular / Irregular
Duration: _____ days / Interval: _____ days
LMP: _____ (certain / uncertain)
Flow: Normal / Heavy / Scanty
Dysmenorrhea: Yes / No

F. CONTRACEPTIVE HISTORY

Method used: None / OCP / Barrier / IUCD / Sterilization

G. MEDICAL & SURGICAL HISTORY

Pre-existing hypertension: Yes / No (duration)
Diabetes mellitus: Yes / No
Renal disease: Yes / No
Cardiac disease: Yes / No
Thyroid disorders: Yes / No
Any surgical procedures: Yes / No

H. FAMILY HISTORY

Hypertension in family: Yes / No (who)
Diabetes: Yes / No
Pre-eclampsia/eclampsia in mother/sister: Yes / No
Twins: Yes / No

I. PERSONAL HISTORY

Diet: Vegetarian / Mixed
Appetite: Normal / Decreased
Sleep: Normal / Disturbed
Bowel & Bladder habits
Addiction: Smoking / Alcohol / Tobacco

J. GENERAL EXAMINATION

Parameter	Finding
General condition	Good / Moderate / Poor
Conscious	Yes / No
Orientation	Oriented / Disoriented
Pallor	Absent / Present (+/++)
Icterus	Absent / Present
Cyanosis	Absent / Present
Lymphadenopathy	Absent / Present
Clubbing	Absent / Present
Edema	Absent / Pedal / Facial / Generalized (pitting/non-pitting)
Height	cm
Weight	kg
BMI	kg/m²

Vital Signs:

Parameter	Finding
Temperature	°F
Pulse	/min, character
Blood Pressure	mmHg (Right arm, sitting)
Respiratory rate	/min
SpO2	%

K. SYSTEMIC EXAMINATION

Cardiovascular System:

Heart sounds: S1 S2 heard / Murmurs

Respiratory System:

Air entry: Bilateral equal / Reduced
Added sounds: Crepts / Wheeze / Absent

CNS:

Conscious / Oriented
Deep tendon reflexes: Normal / Exaggerated / Absent
Plantars: Flexor / Extensor

Abdomen: (Obstetric examination below)

L. OBSTETRIC EXAMINATION

Inspection:

Shape of abdomen: Ovoid / Longitudinal / Transverse
Size: Corresponding to POG / More / Less
Umbilicus: Centered / Deviated / Everted / Inverted
Linea nigra: Present / Absent
Striae: Gravidarum / Albicans
Fetal movements: Visible / Not visible
Scars: LSCS / Laparotomy

Palpation:

Uterine size: Corresponds to _____ weeks
Fundal height: _____ cm (from pubic symphysis)
Fundal grip: Breech / Head (soft, irregular, non-ballotable / hard, round, ballotable)
Lateral / Umbilical grip: Back on _____ side / Limbs on _____ side
Pelvic grip: Presenting part: Head / Breech / Shoulder
Engagement: 5/5 / 4/5 / 3/5 / 2/5 / 1/5 / 0/5 above pelvic brim
Liquor: Adequate / Reduced / Increased

Auscultation:

Fetal heart sounds: Heard / Not heard
Rate: _____ /min
Location: _____ quadrant

Pelvic Assessment / Per Vaginum (if indicated):

Cervix: Favorable / Unfavorable (Bishop score)
Presentation
Station

M. INVESTIGATIONS

Investigation	Result	Normal Value
Hemoglobin		>11 g/dL in pregnancy
PCV
Platelet count		>1,50,000
Blood group & Rh
Random blood sugar		<140 mg/dL
Urine routine	Albumin: / Pus cells: / RBC:	Albumin: Nil
Serum creatinine		<0.9 mg/dL
Serum uric acid		<5.5 mg/dL in pregnancy
SGOT / SGPT		<40 U/L
LDH		<600 U/L
Peripheral smear
S. Bilirubin
Coagulation profile (PT, aPTT, INR)
USG abdomen	BPD / AC / FL / AFI / Placenta / Doppler
CTG	Reactive / Non-reactive

PART 2 - PRESENTATION WITH "WHY" OF EVERY HISTORY

WHY we ask each question - Rationale

Age

Why ask? Pre-eclampsia is more common at extremes of age - teenage mothers (<18 yrs) due to immunological immaturity and primipaternity effect, and elderly primigravida (>35 yrs) due to vascular insufficiency and underlying comorbidities.

Gravida/Parity

Why ask? Pre-eclampsia is predominantly a disease of primigravidaa (6-8x higher risk). Multigravidae with a new partner are at risk again (primipaternity theory - immune maladaptation). Previous pre-eclampsia increases recurrence risk by 20-25%.

Chief Complaint - Swelling of Feet/Face

Why ask? Edema in pre-eclampsia is pathological - it is non-dependent, rapid in onset, and involves the face. It results from hypoalbuminemia + increased capillary permeability due to endothelial damage. Facial puffiness especially on waking is a red flag sign.

Headache

Why ask? Severe headache (frontal or occipital, throbbing) in pre-eclampsia indicates cerebral vasoconstriction and vasogenic edema. It is a warning symptom of impending eclampsia. Must be differentiated from tension headache.

Blurring of Vision / Visual Disturbances

Why ask? Indicates retinal arteriolar spasm, retinal edema, or impending cortical blindness (amaurosis). Scotomata and photopsia suggest severe pre-eclampsia and impending eclampsia. Amaurosis (cortical blindness) may occur post-eclampsia.

Epigastric Pain / Right Hypochondriac Pain

Why ask? This is a classic warning sign! It represents subcapsular hemorrhage of the liver / hepatic ischemia stretching the Glisson's capsule. It also suggests the HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets) - a dreaded complication.

Convulsions (if eclampsia)

Why ask? To classify as antepartum / intrapartum / postpartum eclampsia. Also: number of episodes (recurrent = more dangerous), time gap from last episode, any recovery of consciousness (distinguishes from status epilepticus), any tongue bite, urinary incontinence, or post-ictal confusion.

Oliguria / Decreased Urine Output

Why ask? Indicates renal involvement - pre-eclamptic kidneys show glomerular endotheliosis, leading to proteinuria and reduced GFR. Oliguria (<30 mL/hr) is a severe feature and signals impending renal failure.

Decreased Fetal Movements

Why ask? Pre-eclampsia causes uteroplacental insufficiency due to inadequate trophoblastic invasion of spiral arteries and endothelial dysfunction. This leads to IUGR, chronic fetal hypoxia, and fetal distress. Reduced FM is an alarming sign.

POG at Onset of Symptoms

Why ask? Pre-eclampsia by definition occurs after 20 weeks of gestation. Onset before 34 weeks = early-onset (more severe, worse maternal/fetal outcomes). Onset at term = late-onset (milder, better prognosis).

LMP and EDD

Why ask? To accurately calculate gestational age, which determines: (a) whether it's pre-eclampsia vs chronic hypertension, (b) maturity of fetus for decision about delivery timing, (c) prematurity risk if early delivery needed.

ANC History

Why ask? To know baseline BP (pre-existing hypertension vs gestational), previous urine albumin reports, any previous abnormal labs (renal/liver), compliance with iron/calcium supplementation (low calcium is a risk factor for pre-eclampsia).

Previous Obstetric History

Why ask? Previous pre-eclampsia/eclampsia = 20-25% recurrence risk. Previous intrauterine death, IUGR, or abruption may suggest prior undetected hypertensive disease. Previous preterm delivery may hint at severe disease.

Family History of Hypertension / Pre-eclampsia

Why ask? Pre-eclampsia has a genetic component - daughters of eclamptic mothers have 20-25% risk; sisters have similar risk. Positive family history supports immune/genetic predisposition.

Medical History - Chronic Hypertension

Why ask? Superimposed pre-eclampsia on chronic hypertension is the most dangerous combination - much higher risk of abruption, renal failure, and maternal death. Baseline BP before 20 weeks must be known.

Medical History - Renal Disease

Why ask? Renal disease mimics pre-eclampsia (proteinuria + hypertension). Also, renal disease is a major risk factor for pre-eclampsia. Serum creatinine and previous urine reports help distinguish.

Medical History - Diabetes

Why ask? Diabetes increases risk of pre-eclampsia 2-4 fold due to vascular endothelial dysfunction and microangiopathy. Pre-gestational diabetes > gestational diabetes in risk.

Socioeconomic Status

Why ask? Low SES is associated with poor nutrition (low calcium, protein), poor ANC attendance, inadequate supplementation, more physical work - all risk factors for pre-eclampsia.

Twins / Multiple Pregnancy (from Obstetric History)

Why ask? Multiple pregnancy increases pre-eclampsia risk 3-5x due to larger placental mass and excessive trophoblast-derived angiogenic factors (excess sFlt-1).

PART 3 - CAUSES AND DIFFERENTIAL DIAGNOSIS

HYPERTENSIVE DISORDERS OF PREGNANCY - Classification (ISSHP 2018 / ACOG)

1. Gestational Hypertension

BP ≥ 140/90 mmHg after 20 weeks of gestation
No proteinuria, no severe features
Resolves within 12 weeks postpartum
~50% progress to pre-eclampsia

2. Pre-eclampsia

BP ≥ 140/90 mmHg after 20 weeks + Proteinuria (≥300 mg/24hr or urine PCR ≥0.3 or dipstick 2+)
OR BP ≥ 140/90 + any severe feature (even without proteinuria):
- Thrombocytopenia (<1,00,000)
- Renal insufficiency (creatinine >1.1 mg/dL)
- Impaired liver function (elevated transaminases)
- Pulmonary edema
- New-onset headache / visual symptoms

3. Severe Pre-eclampsia (Severe Features)

SBP ≥ 160 mmHg OR DBP ≥ 110 mmHg (on 2 readings, 4 hrs apart)
Thrombocytopenia < 1,00,000/μL
Liver enzymes 2x upper limit + RUQ/epigastric pain
Progressive renal insufficiency
Pulmonary edema
New-onset headache / visual disturbances

4. Eclampsia

Pre-eclampsia + Grand mal seizures not attributable to other causes
Can be antepartum (50%), intrapartum (25%), postpartum (25%)
Postpartum eclampsia up to 48 hrs (rarely up to 4 weeks) postpartum

5. HELLP Syndrome

Hemolysis (LDH >600, microangiopathic hemolytic anemia on smear)
Elevated Liver enzymes (AST/ALT > 2x ULN)
Low Platelets (<1,00,000/μL)
Can occur without classic features of pre-eclampsia

6. Chronic Hypertension in Pregnancy

Pre-existing hypertension before 20 weeks or diagnosed before pregnancy

7. Superimposed Pre-eclampsia on Chronic Hypertension

Sudden worsening of BP + new proteinuria in a chronically hypertensive patient
Most dangerous combination

DIFFERENTIAL DIAGNOSIS

Condition	Differentiating Features
Chronic hypertension	Hypertension before 20 weeks, no proteinuria initially
Gestational hypertension	Hypertension after 20 weeks, NO proteinuria, no severe features
Renal disease	Pre-existing proteinuria/hematuria, abnormal creatinine before pregnancy
Primary hyperaldosteronism	Hypokalemia, resistant hypertension, adrenal mass on imaging
Pheochromocytoma	Paroxysmal hypertension, palpitations, sweating, headache
Epilepsy	Pre-existing seizure disorder, no HTN/proteinuria
Intracranial hemorrhage	Sudden focal deficit, CT confirms
Thrombotic Thrombocytopenic Purpura (TTP)	Pentad: MAHA + thrombocytopenia + fever + renal failure + neuro symptoms
Acute Fatty Liver of Pregnancy	Hypoglycemia, jaundice, coagulopathy, predominantly hepatic picture

PART 4 - SUMMARY OF POSITIVE FINDINGS

Model Summary Statement (for examiner):

"Mrs. _____, a ___-year-old gravida _____, para _____, with period of gestation of _____ weeks by dates/ultrasound, booked/unbooked, presented with complaints of swelling of legs and face for _____ days, headache for _____ days, and blurring of vision for _____ days.

On examination, she is conscious and oriented. Pulse is ___/min, Blood pressure is ___/___mmHg. She has pitting pedal edema up to the ankle/knee/thigh. Facial puffiness is present/absent.

On obstetric examination, the uterus corresponds to _____ weeks of gestation, fetus is in longitudinal lie, cephalic presentation, head ___/5 above the pelvic brim. Fetal heart sounds are heard at _____ bpm.

Urine examination shows albumin ++ (significant proteinuria). Deep tendon reflexes are exaggerated.

Based on these findings, a diagnosis of Pre-eclampsia with severe features / Eclampsia / Gestational hypertension at _____ weeks of gestation is made."

PART 5 - EXAMINATION PROCEDURE

Step-by-Step Clinical Examination

Step 1: Approach the patient

Introduce yourself, take consent
Note general appearance: conscious/drowsy, in distress, facial puffiness

Step 2: General Examination

Pallor - Pre-eclampsia can cause hemolysis (HELLP) causing pallor
Icterus - HELLP syndrome hepatic involvement
Edema - Grade it:
- Grade 1: Pedal edema only
- Grade 2: Up to knees
- Grade 3: Up to thighs
- Grade 4: Anasarca (face, ascites, hydrothorax)
- Note: Pitting vs non-pitting, facial puffiness
Blood Pressure Measurement (KEY SKILL):
- Patient seated, arm at heart level
- Use appropriately sized cuff (cuff should cover 80% of arm circumference)
- Record in BOTH arms
- Use Korotkoff phase V (disappearance) for diastolic
- Repeat after 4-6 hours if borderline
- Use mercury/aneroid sphygmomanometer (not automated in suspected PE)

Step 3: Neurological Assessment

Deep Tendon Reflexes:
- Knee jerk (L3-L4): Use patella hammer
- Ankle jerk (S1-S2)
- Grading:
  - 0: Absent
  - 1+: Diminished
  - 2+: Normal
  - 3+: Brisk (pre-eclampsia warning)
  - 4+: Clonus (impending eclampsia)
- Clonus test: Dorsiflex the foot sharply - sustained rhythmic beats = positive clonus = severe pre-eclampsia
Plantar response: Flexor (normal) / Extensor (Babinski positive - CNS involvement)
Fundoscopy (if possible): Arteriolar narrowing, AV nipping, papilledema, retinal hemorrhage

Step 4: Cardiovascular & Respiratory

Auscultate heart and lung bases (pulmonary edema - bilateral crepitations)
Check JVP (elevated = fluid overload)

Step 5: Obstetric Examination

Inspection:
- Shape of abdomen
- Size corresponding to POG
- Scar from previous LSCS
Fundal Height:
- Measure from pubic symphysis to fundus in cm
- Corresponds to weeks ± 2 cm after 20 weeks
- Fundal height < expected POG by >2 cm = IUGR (common in pre-eclampsia)
Leopold's Maneuvers:
- First maneuver (Fundal grip): What is at the fundus? Breech (soft, irregular, non-ballotable) or Head (hard, round, ballotable)
- Second maneuver (Lateral grip): Back on which side? Back = smooth, resistant. Limbs = irregular, nodular
- Third maneuver (Pawlik's grip): Presenting part, mobility (engaged or not)
- Fourth maneuver (Pelvic grip): Degree of engagement
Auscultation: Fetal heart rate at maximum point (at the back of baby, below umbilicus in cephalic)
Liquor assessment: Assess clinically (SFH, ballottement) and confirm by USG AFI

Step 6: Per Speculum / Per Vaginum (if indicated for delivery planning)

Bishop Score assessment
Presenting part and station

PART 6 - DIAGNOSIS WITH EXPLANATION

Diagnostic Criteria

Pre-eclampsia:

BP ≥ 140/90 mmHg (on 2 occasions, 4 hrs apart, after 20 weeks) + Proteinuria (≥300 mg/24hr or dipstick ≥2+)

OR BP ≥ 140/90 + any one of:

Thrombocytopenia < 1,00,000
Renal impairment (creatinine > 1.1 mg/dL)
Liver dysfunction (LFTs > 2x ULN)
Pulmonary edema
New-onset headache / visual symptoms

Severe Pre-eclampsia:

SBP ≥ 160 OR DBP ≥ 110 (even on single reading if patient is symptomatic)

Eclampsia:

Pre-eclampsia + grand mal seizure (not attributable to epilepsy, metabolic cause, or intracranial lesion)

Gestational Hypertension:

BP ≥ 140/90 after 20 weeks, NO proteinuria, NO severe features, resolves < 12 weeks postpartum

Pathophysiology (WHY this happens):

Core mechanism: Defective placentation

Normal: Trophoblasts invade spiral arteries → remodel them → low resistance, high flow vessels Pre-eclampsia: Incomplete invasion → spiral arteries remain narrow, muscular → uteroplacental ischemia → releases soluble factors (sFlt-1, sEng) → Maternal systemic endothelial dysfunction

Consequences of endothelial dysfunction:

Vasospasm → Hypertension
Increased capillary permeability → Edema, proteinuria
Platelet activation → Thrombocytopenia, DIC
Hepatic ischemia → Elevated liver enzymes, epigastric pain
Cerebral vasospasm → Headache, seizures (eclampsia)
Uteroplacental insufficiency → IUGR, fetal distress

PART 7 - CASE DISCUSSION

Key Discussion Points

1. HELLP Syndrome

Occurs in 10-20% of severe pre-eclampsia
Can occur WITHOUT hypertension or proteinuria in 10% cases
Diagnosis: LDH > 600 IU/L, peripheral smear (schistocytes/burr cells), platelets < 1,00,000, AST/ALT > 2x normal
Treatment: Stabilize, correct coagulopathy, steroids if <34 weeks for lung maturity, DELIVER

2. Antihypertensive Therapy in Pregnancy - Safe Drugs

Drug	Mechanism	Safety
Labetalol (IV)	Alpha + beta blocker	Drug of choice for acute severe HTN
Hydralazine (IV)	Direct vasodilator	Alternative IV drug
Nifedipine (oral)	CCB	Oral drug of choice
Methyldopa (oral)	Central alpha-2 agonist	Safe in all trimesters
Avoid: ACE inhibitors, ARBs	Fetotoxic	Renal agenesis, skull ossification defects

3. Magnesium Sulfate - The Cornerstone

Purpose: Prevention and treatment of eclamptic seizures Why MgSO4 works:

Competes with calcium at NMDA receptors → reduces neuronal excitability
Cerebral vasodilation → reduces ischemia
NOT an antihypertensive

Pritchard Regimen (most common in India):

Loading dose: 4 g IV over 15-20 min + 10 g IM (5g each buttock)
Maintenance: 5 g IM every 4 hours (alternating buttocks)

Zuspan Regimen:

Loading: 4 g IV over 15-20 min
Maintenance: 1-2 g/hr IV infusion

Toxicity monitoring (every 4 hours):

Urine output > 25 mL/hr (renal excretion of Mg)
Respiratory rate > 16/min
Deep tendon reflexes present (knee jerk)
Serum Mg level if available (therapeutic: 4-7 mEq/L)

Antidote: Calcium gluconate 1g IV slowly (10 mL of 10% solution)

4. Delivery - The Only Cure

Decision based on:

Gestational age
Maternal condition
Fetal condition (CTG, Doppler, BPP)

Situation	Management
≥37 weeks pre-eclampsia	Deliver (induction or LSCS)
34-37 weeks with severe features	Deliver after steroids
<34 weeks without severe features	Expectant with close monitoring
Eclampsia (any gestation)	Stabilize → Deliver within 12-24 hrs
HELLP syndrome	Deliver regardless of gestation

5. Postpartum Management

MgSO4 to be continued for 24-48 hrs postpartum
BP monitoring for at least 72 hrs postpartum
Antihypertensives if BP persists
Urine albumin rechecks at 6 weeks
Counsel on recurrence risk

PART 8 - INVESTIGATIONS AND MANAGEMENT

Investigations

Baseline / Mandatory:

Urine routine - albumin (dipstick or 24-hr protein)
CBC - Hb, platelets (thrombocytopenia in HELLP)
Blood group and Rh typing
LFT - SGOT, SGPT, LDH, serum bilirubin
RFT - Serum creatinine, uric acid, urea
Blood sugar - FBS, PPBS
Coagulation profile - PT, aPTT, INR, fibrinogen
Peripheral smear - Schistocytes (HELLP), malarial parasite
Serum uric acid - elevated in pre-eclampsia (marker of severity)

Fetal Assessment:

USG with Biometry - AFI, estimated fetal weight, growth, placental grade
Doppler studies:
- Umbilical artery Doppler: Absent/Reversed end-diastolic flow = severe fetal compromise
- Middle Cerebral Artery (MCA) Doppler: Brain sparing effect (PI < 1.0)
- Cerebroplacental ratio
- Uterine artery Doppler (notching = placental insufficiency)
CTG (Cardiotocography): Reactive / Non-reactive
Biophysical Profile (BPP): Score of 8-10 = normal

Management

Immediate Stabilization (ABCDE approach):

A - Airway: Left lateral position, airway protection B - Breathing: O2 by mask if SpO2 < 95% C - Circulation: IV access x2, fluid restriction (80 mL/hr or 1 mL/kg/hr - avoid fluid overload) D - Drugs:

MgSO4 (Pritchard/Zuspan regimen) - seizure prophylaxis/control
Antihypertensives: Labetalol IV / Hydralazine IV / Nifedipine oral E - Evaluation: Urine output (catheterize), labs, fetal monitoring

If Seizure (Eclampsia):

Call for help, left lateral position, protect airway
MgSO4 4g IV over 5-10 min (recurrence dose: 2g IV)
If refractory: Diazepam 5-10mg IV OR Phenytoin
Stabilize for minimum 30-60 min before delivery
Delivery plan: Vaginal preferred if cervix favorable; LSCS if not

Antihypertensive Protocol (Acute Severe HTN):

Target: SBP 140-155, DBP 90-105 (avoid rapid lowering - uteroplacental compromise)
Labetalol 20mg IV → if no response in 10 min → 40mg → 80mg → max 300mg
OR Hydralazine 5mg IV → repeat 5-10mg every 20 min
OR Nifedipine 10mg oral → repeat after 30 min if needed (NOT sublingual)

Definitive Treatment - Delivery:

Mode: Vaginal delivery preferred, LSCS for obstetric indications
Anesthesia: Spinal preferred (avoid GA if possible - reduces laryngeal complications)
Third stage: Oxytocin preferred (avoid Ergometrine - raises BP further)
Postpartum: Continue MgSO4 for 24-48 hrs

Prevention (Aspirin for High-Risk Patients):

Low-dose aspirin 75-150 mg/day from 11-14 weeks (before 16 weeks ideally)
Indicated if: ≥1 high-risk factor OR ≥2 moderate-risk factors
High-risk factors: Previous pre-eclampsia, chronic HTN, renal disease, DM, autoimmune disease, multifetal

PART 9 - VIVA QUESTIONS AND ANSWERS

Q1. What is the definition of pre-eclampsia? A: Pre-eclampsia is defined as hypertension (BP ≥ 140/90 mmHg on two occasions ≥4 hours apart) arising after 20 weeks of gestation, accompanied by proteinuria (≥300 mg/24hrs or urine PCR ≥0.3 or dipstick 2+), OR in the absence of proteinuria, the presence of any severe feature such as thrombocytopenia, renal insufficiency, impaired liver function, pulmonary edema, or new-onset neurological symptoms.

Q2. Why is pre-eclampsia called a "disease of theories"? A: Because the exact etiology is still not fully understood. Multiple theories exist: immunological (failure of maternal tolerance to paternal antigens), genetic (multifactorial inheritance), placental ischemia (defective trophoblastic invasion), oxidative stress, endothelial dysfunction, and prostacyclin-thromboxane imbalance. No single theory fully explains all aspects.

Q3. Why does pre-eclampsia occur predominantly in primigravidae? A: The "primipaternity" theory suggests that first exposure to paternal (foreign) antigens in primigravidae triggers inadequate immune tolerance, leading to failure of normal trophoblastic invasion. In subsequent pregnancies with the same partner, immune tolerance develops. However, a new partner resets this risk (hence "new partner effect").

Q4. What is the significance of deep tendon reflexes in pre-eclampsia? A: Exaggerated deep tendon reflexes (3+) indicate cortical irritability due to cerebral vasospasm and edema - a warning sign of impending eclampsia. Sustained ankle clonus (>3 beats) is an ominous sign. Before administering MgSO4 maintenance doses, reflexes MUST be checked - absence of reflexes is a sign of magnesium toxicity.

Q5. What is MgSO4 and why is it used instead of anticonvulsants? A: MgSO4 is the drug of choice for seizure prophylaxis and treatment in eclampsia. It works by: (a) competing with calcium at NMDA receptors, reducing neuronal excitability; (b) producing cerebral vasodilation, reducing ischemia; (c) stabilizing endothelial membranes. Studies (Magpie Trial) showed MgSO4 is superior to diazepam and phenytoin in preventing recurrent eclamptic seizures and maternal mortality.

Q6. What is HELLP syndrome? How do you diagnose it? A: HELLP = Hemolysis, Elevated Liver enzymes, Low Platelets. It complicates 10-20% of severe pre-eclampsia. Diagnosed by: LDH >600 IU/L + schistocytes on peripheral smear (hemolysis), SGOT/SGPT >2x upper limit of normal (liver), platelets <1,00,000/μL. Tennessee classification (Mississippi modification) grades it by platelet count severity. It can occur WITHOUT hypertension or proteinuria.

Q7. How will you differentiate eclampsia from epilepsy? A: Eclampsia: onset after 20 weeks, hypertension + proteinuria present, no prior seizure history, seizures resolve after delivery. Epilepsy: prior history, normal BP/urine, no correlation with pregnancy, seizures respond to anticonvulsants, EEG abnormal, no postpartum resolution.

Q8. What is the Pritchard regimen? A: Loading dose: 4g MgSO4 IV over 15-20 min + 10g IM (5g in each buttock as 50% solution). Maintenance: 5g IM every 4 hours in alternating buttocks. Monitoring: urine output >25 mL/hr, RR >16/min, knee jerk present. Antidote: Calcium gluconate 1g IV.

Q9. Why is ACE inhibitor/ARB contraindicated in pregnancy? A: ACE inhibitors and ARBs cross the placenta and cause fetal renal tubular dysplasia, oligohydramnios (Potter sequence), renal agenesis, skull ossification defects, and neonatal renal failure. They are absolutely contraindicated from the second trimester onward, and ideally avoided in the first trimester too.

Q10. What is the role of aspirin in pre-eclampsia prevention? A: Low-dose aspirin (75-150 mg/day) inhibits platelet thromboxane A2 while sparing vascular prostacyclin, restoring the prostacyclin:thromboxane balance. It also improves trophoblastic invasion by reducing inflammation. Started before 16 weeks in high-risk patients, it reduces pre-eclampsia risk by ~10-25% (ASPRE trial).

Q11. What is Doppler umbilical artery AEDV/REDV and what does it signify? A: Absent End-Diastolic Velocity (AEDV) or Reversed End-Diastolic Velocity (REDV) in umbilical artery Doppler indicates severe uteroplacental insufficiency with very high vascular resistance. AEDV = 70-80% chance of neonatal morbidity. REDV = >90% perinatal mortality if untreated. It is an indication for urgent delivery.

Q12. Which antihypertensives are safe in pregnancy? A: Safe: Methyldopa (1st line oral), Labetalol (IV for acute, oral for chronic), Nifedipine (oral CCB), Hydralazine (IV acute). Unsafe/contraindicated: ACE inhibitors, ARBs, Atenolol (IUGR risk), Sodium nitroprusside (cyanide toxicity). Diuretics: avoided unless pulmonary edema.

Q13. What is the only definitive treatment for pre-eclampsia? A: Delivery of the baby and placenta. Pre-eclampsia is a disease of the placenta; all symptoms, signs, and pathological changes resolve after placental delivery. The timing and mode depend on gestational age, severity of disease, and fetal/maternal condition.

Q14. What are the long-term maternal risks after pre-eclampsia? A: Women with prior pre-eclampsia have significantly higher lifetime risk of: cardiovascular disease (coronary artery disease, stroke - 2x risk), hypertension (4x risk), chronic kidney disease, and metabolic syndrome. They need long-term cardiovascular follow-up.

Q15. What is "postpartum eclampsia"? When does it occur? A: Eclampsia occurring after delivery. Most commonly within 48 hours postpartum (late postpartum eclampsia). Can rarely occur up to 4 weeks postpartum. Importance: (a) must continue MgSO4 for 24-48 hrs postpartum, (b) new-onset seizures in the puerperium must always be considered eclampsia until proven otherwise, (c) associated with worse neurological outcomes if late diagnosis.

Ready for the Next Case!

That completes Long Case 1: Hypertensive Disorders in Pregnancy (Pre-eclampsia / Eclampsia / Gestational Hypertension).

Say "next" for Long Case 2: Anemia Complicating Pregnancy. Each case will follow the same thorough format. All cases are based on standard OBG teaching including the approach outlined in Hephzibah Kirubamani's practical OBG textbook.

Finding Sources

Reading File

Finding Sources

Reading File

Excellent! I have enough from the textbooks to build the complete case. Here is Long Case 2:

LONG CASE 2: ANEMIA COMPLICATING PREGNANCY

PART 1 - CASE SHEET (PROFORMA)

OBSTETRIC CASE SHEET - ANEMIA IN PREGNANCY

Date: _____________ IP No: _____________ Ward: _____________

A. PERSONAL DETAILS


Name
Age
G P L A
Address
Occupation
Socioeconomic status	Low / Middle / High
Diet	Vegetarian / Mixed
Religion

B. CHIEF COMPLAINTS

Breathlessness on exertion since _____ weeks
Fatigue / easy fatigability since _____
Palpitations since _____
Giddiness / fainting since _____
Pallor noticed since _____
Swelling of feet since _____
Decreased fetal movements (if applicable)

C. HISTORY OF PRESENT ILLNESS

Duration and onset of symptoms
Progression: gradual / rapid
Breathlessness grade (MRC/NYHA)
Any bleeding episode - antepartum hemorrhage, hematuria, hematemesis
Pica - craving for mud/clay/chalk/ice (pagophagia)
Recent infections - fever, worm infestation
Dietary history: strict vegetarian, poor intake of iron/folate-rich foods

D. OBSTETRIC HISTORY

Present Pregnancy:

LMP: _________ EDD: _________
POG: _____ weeks
Booking status: Booked / Unbooked
ANC visits: number, compliance with iron-folic acid (IFA) tablets
Number of IFA tablets taken per day / any vomiting / non-compliance
USG findings: growth scan, AFI, Doppler
Previous Hb reports during ANC

Previous Obstetric History:

Pregnancy	Year	GA	Delivery	Sex	BW	Outcome	Complications
1
2

Close birth spacing (< 2 years) - a major risk factor
History of previous heavy bleeding (PPH)
Previous babies with congenital malformations (folate deficiency)

E. MENSTRUAL HISTORY

Menorrhagia: heavy, prolonged periods - major cause of pre-pregnancy iron depletion
Dysmenorrhea
LMP certainty

F. MEDICAL & SURGICAL HISTORY

Malaria (chronic, recurrent): causes hemolytic anemia
Intestinal worm infestation (hookworm): chronic occult blood loss - major cause
Sickle cell disease / Thalassemia: known hemoglobinopathy
G6PD deficiency
Renal disease (anemia of chronic disease)
Previous gastric surgery (B12 deficiency)
Celiac disease / malabsorption (iron/folate/B12 deficiency)

G. FAMILY HISTORY

Thalassemia / sickle cell disease in family
Consanguineous marriage (risk for hemoglobinopathy)
Similar illness in siblings

H. PERSONAL HISTORY

Diet: strictly vegetarian (risk for B12/iron deficiency)
Tea/coffee intake after meals (tannins inhibit iron absorption)
Tobacco/paan chewing
Socioeconomic status: poverty = poor diet quality

I. GENERAL EXAMINATION

Parameter	Finding
General condition
Pallor	Absent / Mild / Moderate / Severe (conjunctival/palmar/mucosal)
Icterus	Absent / Present (hemolytic anemia / folate deficiency)
Angular stomatitis	Absent / Present (B12/iron deficiency)
Glossitis / Smooth tongue	Absent / Present (B12/iron)
Koilonychia (spoon nails)	Absent / Present (iron deficiency)
Brittle nails / Hair	Absent / Present
Edema	Absent / Pedal
Lymphadenopathy	Absent / Present
Pulse	Rate, volume (high-volume bounding = anemia)
BP
Temperature	(fever = infection/malaria)
SpO2
BMI

J. SYSTEMIC EXAMINATION

Cardiovascular:

Cardiomegaly (displaced apex), tachycardia
Systolic flow murmur (hemic murmur) - present in severe anemia
Signs of cardiac failure (in very severe anemia)

Respiratory:

Air entry, added sounds

Abdomen:

Splenomegaly (malaria, hemolytic anemia, thalassemia)
Hepatomegaly

K. OBSTETRIC EXAMINATION

Inspection: Fundal height, fetal movements, scars

Palpation:

Fundal height (IUGR - smaller than dates, common in severe anemia)
Lie, presentation, position
Engagement
Liquor adequacy

Auscultation: FHR (fetal distress in severe anemia)

L. INVESTIGATIONS

Investigation	Result	Normal (Pregnancy)
Hemoglobin		≥11 g/dL
PCV / Hematocrit		≥33%
MCV		81-99 fL
MCH		27-32 pg
MCHC		32-36 g/dL
RDW		<14.5%
Peripheral smear		Normocytic normochromic
Reticulocyte count		0.5-1.5%
Serum ferritin		>20 μg/L
Serum iron		44-193 μg/dL
TIBC		235-597 μg/dL
Transferrin saturation		16-60%
Serum folate		26-207 μg/L
Serum B12		99-656 pg/mL
Stool for ova and parasites
Urine routine
Blood group & Rh
Hb electrophoresis		HbA >98%, HbA2 <3.5%
Sickle cell test		Negative
G6PD screen		Normal
USG + Doppler	BPP, AFI, EFW, UA Doppler
CTG

PART 2 - PRESENTATION WITH "WHY" OF EVERY HISTORY

WHY we ask each question - Rationale

Age

Why ask? Teenage mothers are growing themselves - increased nutritional demands compete with the pregnancy, leading to greater risk of iron and folate deficiency. Elderly multigravidae with close birth spacing have chronically depleted iron stores.

Socioeconomic Status

Why ask? Low SES is the single most important risk factor for nutritional anemia in developing countries like India. It correlates with: poor dietary quality, lack of variety, inability to afford iron-rich foods (meat, eggs, green leafy vegetables), and poor awareness of supplementation.

Diet - Vegetarian vs Mixed

Why ask? Non-heme iron (from plant sources) has only 1-5% bioavailability vs heme iron (from meat) at 20-30%. Strict vegetarians have much lower absorbable iron intake. Vitamin B12 is found ONLY in animal products - strict vegans are at high risk for megaloblastic anemia.

Chief Complaint - Breathlessness

Why ask? Dyspnea on exertion is a cardinal symptom of moderate-severe anemia (Hb <7 g/dL). In anemia, reduced oxygen-carrying capacity compensated by increased cardiac output causes exertional dyspnea. Grading (mild = on heavy exertion, moderate = on mild exertion, severe = at rest) correlates with severity.

Fatigue / Easy Fatigability

Why ask? Indicates tissue hypoxia - cells are not receiving adequate oxygen. Also reflects depleted muscle myoglobin (iron-containing protein). Fatigue precedes anemia - occurs in "iron deficiency without anemia" stage (latent iron deficiency).

Palpitations

Why ask? Anemia causes compensatory increase in cardiac output via tachycardia and increased stroke volume. Patient experiences this as palpitations. Severe anemia can cause high-output cardiac failure.

Pica

Why ask? Pica (craving for unusual non-food substances) is strongly associated with iron deficiency anemia - particularly pagophagia (ice), geophagia (clay/mud), and amylophagia (starch). Mechanism unclear but corrects with iron therapy. Very common in rural Indian women with IDA.

IFA Tablet Compliance

Why ask? The Government of India recommends 1 IFA tablet (100mg elemental iron + 500 μg folic acid) daily from first trimester. Non-compliance due to side effects (nausea, constipation, black stools), forgetfulness, or vomiting is the most common cause of preventable anemia in pregnancy.

Tea/Coffee After Meals

Why ask? Tannins in tea and phytates in cereals/pulses bind iron in the gut and reduce non-heme iron absorption by up to 40-60%. This is a very important dietary counseling point. Vitamin C enhances absorption by reducing ferric to ferrous iron.

Close Birth Spacing

Why ask? Interpregnancy interval <2 years does not allow restoration of iron stores depleted during the previous pregnancy and lactation. This is one of the most common causes of severe anemia in high-parity Indian women (grand multipara).

History of Menorrhagia

Why ask? Menorrhagia causes pre-pregnancy iron depletion. Each heavy period may cause loss of 40-80 mL blood (20-40 mg iron). If stores are already depleted entering pregnancy, even modest additional demands cause significant anemia.

Worm Infestation

Why ask? Hookworm (Ancylostoma duodenale / Necator americanus) causes chronic occult gastrointestinal blood loss - 0.03 to 0.2 mL blood per worm per day. A single heavy worm load can cause severe IDA. Check stool for ova and cysts. Common in tropical countries.

Malaria History

Why ask? Recurrent malaria causes hemolytic anemia (destruction of RBCs) + suppression of erythropoiesis + increased iron sequestration (hepcidin induction). Falciparum malaria can cause severe acute hemolysis (blackwater fever).

Family History of Hemoglobinopathy

Why ask? Thalassemia trait and sickle cell trait are autosomal recessive. If both parents are carriers, there is a 25% risk of a severely affected child. Partner testing is essential. Thalassemia major in pregnancy (rare) causes severe hemolytic anemia requiring transfusion.

Previous Obstetric History - Grand Multiparity

Why ask? Each pregnancy consumes ~1000mg of iron (fetal needs 300mg + placenta + blood loss at delivery). Grand multipara (G4+) with poor diet and short spacing are at very high risk of severe anemia.

Numbness / Tingling in Hands and Feet

Why ask? Subacute combined degeneration of spinal cord - a feature of B12 deficiency (megaloblastic anemia). Also: glossitis, angular stomatitis, neuropsychiatric symptoms. If these are present, investigate B12 levels.

Previous Gastric Surgery

Why ask? Gastrectomy removes parietal cells that produce intrinsic factor (IF) → IF deficiency → B12 malabsorption → pernicious anemia. Also, gastric acid and IF are needed for iron absorption in the duodenum.

PART 3 - CAUSES AND DIFFERENTIAL DIAGNOSIS

Classification of Anemia in Pregnancy

By Hemoglobin Level (WHO / India ICMR):

Grade	Hemoglobin	Clinical Significance
Mild	10-10.9 g/dL	Minimal symptoms
Moderate	7-9.9 g/dL	Symptoms on exertion
Severe	4-6.9 g/dL	Symptoms at rest, high-output state
Very Severe / Dangerous	< 4 g/dL	Risk of cardiac failure, maternal death

Note: Anemia in pregnancy = Hb < 11 g/dL (first and third trimester) or < 10.5 g/dL (second trimester - due to hemodilution peak)

Causes by Morphology:

1. Microcytic Hypochromic (Low MCV, Low MCH, Low MCHC)

Iron Deficiency Anemia (IDA) - most common (>80% in India)
Thalassemia trait (alpha/beta)
Anemia of chronic disease/infection
Sideroblastic anemia (rare)

2. Normocytic Normochromic (Normal MCV, Normal MCH)

Acute blood loss anemia
Hemolytic anemia (malaria, sickle cell disease, G6PD deficiency)
Aplastic anemia
Anemia of chronic disease
Early IDA

3. Macrocytic (High MCV)

Megaloblastic anemia - Folate deficiency (most common macrocytic in pregnancy) / B12 deficiency
Liver disease
Hypothyroidism

Differential Diagnosis:

Diagnosis	Key Distinguishing Features
Iron Deficiency Anemia	Low ferritin (<20 μg/L), low serum iron, high TIBC, microcytic hypochromic smear, koilonychia, pica
Folate Deficiency	Macrocytic anemia, low serum folate, hypersegmented neutrophils, megaloblasts on smear, no neurological signs
B12 Deficiency	Macrocytic, low B12, hypersegmented neutrophils, neurological signs (subacute combined degeneration), vegans
Thalassemia Trait	Microcytic, normal/high ferritin, HbA2 >3.5% (beta trait), Hb electrophoresis diagnostic, family history
Sickle Cell Disease	Normocytic, HbS on electrophoresis, sickle cells on smear, painful crises, jaundice
Malarial Anemia	Fever, splenomegaly, positive MP smear/RDT, hemolytic anemia
Aplastic Anemia	Pancytopenia, hypocellular marrow on biopsy
Physiologic Anemia of Pregnancy	Hb 10.5-11, MCV and MCHC normal, no symptoms, resolves postpartum

PART 4 - SUMMARY OF POSITIVE FINDINGS

Model Summary Statement:

"Mrs. _____, a ___-year-old gravida _____, para _____, with a period of gestation of _____ weeks, unbooked / booked (poor ANC compliance), vegetarian diet, low socioeconomic status, presented with complaints of breathlessness on exertion for _____ weeks, fatigue, and palpitations.

On examination, she has moderate / severe pallor of conjunctiva, palms, and mucous membranes. There is angular stomatitis / koilonychia / smooth tongue present / absent. Pulse is ___/min, tachycardia present / absent.

On obstetric examination, the uterus corresponds to _____ weeks, fetal heart rate is ___/min. Fundal height is less than expected for dates suggesting IUGR.

Hemoglobin is _____ g/dL. Peripheral smear shows microcytic hypochromic red blood cells. Serum ferritin is _____ μg/L.

A diagnosis of Iron Deficiency Anemia / Megaloblastic Anemia / Hemolytic Anemia complicating pregnancy at _____ weeks is made."

PART 5 - EXAMINATION PROCEDURE

Step-by-Step Clinical Examination

Step 1: General Appearance

Note pallor visible on first look
Facial puffiness, jaundice, signs of chronic illness

Step 2: Assess Pallor Systematically

Four sites - examine all:

Conjunctival pallor - pull down lower lid, look at palpebral conjunctiva (most sensitive)
Palmar pallor - compare with examiner's palm; look at palmar creases
Mucosal pallor - buccal mucosa, lip mucosa
Nail bed pallor - press and release; note blanching

Grade pallor:

Mild: Conjunctival only
Moderate: Conjunctival + palmar
Severe: All sites including tongue

Step 3: Look for Specific Signs of Iron Deficiency

Koilonychia (spoon-shaped nails) - in chronic IDA
Angular stomatitis (cracking at corners of mouth)
Atrophic glossitis (smooth, red tongue, loss of papillae)
Brittle, ridged nails
Thin, dry hair
Blue sclerae (iron deficiency)
Pica - ask directly

Step 4: Signs of B12/Folate Deficiency (Megaloblastic)

Hunter's glossitis - beefy red smooth tongue
Angular stomatitis
Peripheral neuropathy - test sensation, vibration
Subacute combined degeneration - check proprioception, Romberg's sign

Step 5: Cardiovascular Signs (Severity Assessment)

Pulse: Tachycardia, full/bounding pulse (high-output state)
Apex beat: Displaced (cardiomegaly in severe chronic anemia)
Hemic systolic murmur: Soft ejection systolic murmur, all areas, best at pulmonary area, diminishes on inspiration - benign flow murmur of anemia
Gallop rhythm: If cardiac failure developing
JVP elevation: Cardiac failure
Bibasal creps: Pulmonary edema (severe anemia + cardiac failure)

Step 6: Splenomegaly and Hepatomegaly

Enlarged spleen: malaria, hemolytic anemia, thalassemia, sickle cell disease
Tender hepatomegaly: malaria, infectious hepatitis

Step 7: Obstetric Examination

Fundal height (IUGR smaller than dates)
Fetal heart rate and pattern (CTG if indicated)
Liquor volume (oligohydramnios with IUGR in severe anemia)

PART 6 - DIAGNOSIS WITH EXPLANATION

Diagnostic Approach

Step 1: Is it anemia?

Hb < 11 g/dL (first/third trimester) or < 10.5 g/dL (second trimester)

Step 2: What type of anemia?

MCV/MCH/MCHC → Microcytic / Normocytic / Macrocytic
Peripheral smear: morphology of RBCs

Step 3: What is the etiology?

If Microcytic Hypochromic:

Serum ferritin (most sensitive indicator of iron stores - falls first)
Ferritin < 20 μg/L = iron deficiency (even before Hb falls)
Ferritin < 12 μg/L = severe depletion
Serum iron: decreased in IDA
TIBC: increased in IDA (as body tries to capture more iron)
Transferrin saturation < 16% = IDA
Hb electrophoresis: to rule out thalassemia trait (HbA2 > 3.5% = beta thal trait)
NOTE: Thalassemia trait - ferritin is NORMAL, MCV very low, RBC count HIGH

If Macrocytic:

Serum folate (low in folate deficiency)
Serum B12 (low in B12 deficiency)
Peripheral smear: hypersegmented neutrophils (>5 lobes in >5% = megaloblastic)
Bone marrow (rarely needed)

If Normocytic:

Reticulocyte count: high = hemolytic/hemorrhagic; low = aplasia
LDH, bilirubin (elevated in hemolysis)
Coombs test (immune hemolysis)
MP smear (malaria)
HbS test (sickle cell)

Most Common Diagnosis: Iron Deficiency Anemia (IDA)

Explanation: India has highest burden of IDA in the world (50-60% of pregnant women affected). Pre-pregnancy stores are usually marginal (two-thirds of healthy women have minimal marrow iron stores - Creasy & Resnik). Pregnancy imposes a total iron demand of ~1000 mg (300mg fetal/placental, 500mg expanded RBC mass, 200mg obligatory losses). Most Indian vegetarian women cannot meet this from diet alone. Hence supplementation is the cornerstone of prevention.

PART 7 - CASE DISCUSSION

Key Discussion Points

1. Iron Metabolism in Pregnancy

Normal changes:

Blood volume increases 40-45% by 34 weeks (plasma +47%, RBC mass only +17%)
This creates "physiologic hemodilution" - Hb falls normally to ~10.5-11 g/dL (normal, NOT anemia)
MCV and MCHC do NOT change in physiologic anemia
If MCV/MCHC fall progressively = true IDA developing

Iron absorption in pregnancy:

Dramatically increases in second and third trimesters (up to 25-30% absorption vs normal 10%)
Facilitated by low gastric pH and increased transferrin receptor expression in gut
Despite this, if stores are depleted, anemia develops

2. IDA - Sequential Stages of Iron Depletion

Stage	Ferritin	Serum Iron	TIBC	Hb	MCV/MCH
Iron depletion	↓ (<20)	Normal	Normal	Normal	Normal
Iron-deficient erythropoiesis	↓↓	↓	↑	Normal	↓
Iron deficiency anemia	↓↓↓	↓↓	↑↑	↓	↓↓

3. Effect on Mother

Severity	Maternal Effect
Mild	Usually asymptomatic, reduced work capacity
Moderate	Fatigue, dyspnea on exertion, palpitations
Severe	High-output cardiac failure, preterm labor, increased susceptibility to infection
Very severe	Maternal death, cardiac decompensation

Increased risk of PPH (poor uterine contractility in severe anemia)
Increased operative morbidity (wound healing, infection)
Reduced immunity (cell-mediated immunity impaired in IDA)

4. Effect on Fetus/Neonate

IUGR - uteroplacental insufficiency in severe anemia
Preterm birth
Low birth weight (2.5x risk with severe anemia)
Neonatal anemia (iron stores depend on maternal status in 3rd trimester)
Impaired cognitive development and brain myelination in the neonate
Fetal distress during labor

5. Megaloblastic Anemia (Folate Deficiency)

Why folate is critical:

DNA synthesis requires folate (thymidylate synthesis)
Deficiency → impaired DNA replication → megaloblastic change in rapidly dividing cells
Neural tube defects (spina bifida, anencephaly) - folic acid periconceptional supplementation is THE prevention
Folate demand increases 5-10x in pregnancy
Folate-rich foods: green leafy vegetables, legumes, liver
IFA tablets in India contain 500 μg folic acid (well above minimum 400 μg needed)

PART 8 - INVESTIGATIONS AND MANAGEMENT

Investigations

Mandatory (All Cases):

Hemoglobin (CBC), PCV
MCV, MCH, MCHC, RDW
Peripheral smear
Blood group and Rh typing
Serum ferritin (most sensitive early marker)
Serum iron, TIBC, transferrin saturation
Urine routine
Stool for ova and cysts (hookworm)
Hb electrophoresis (if microcytic with normal/high ferritin, or positive family history)
Sickle cell solubility test

Additional (Based on Type):

Serum folate, B12 (macrocytic anemia)
Reticulocyte count (hemolytic anemia assessment)
LDH, bilirubin, Coombs test (hemolysis)
MP smear / RDT (if fever + splenomegaly)
G6PD screen

Fetal Assessment:

USG biometry (for IUGR)
Umbilical artery Doppler
CTG / BPP

Management

Prevention (ANC Prophylaxis):

IFA tablets: 1 tablet (100mg elemental iron + 500μg folic acid) daily from first trimester (Government of India NTCP program)
Dietary counseling: iron-rich foods (jaggery, green leafy vegetables, legumes, dates, meat), vitamin C with iron
Deworming: Albendazole 400mg single dose at 14-16 weeks (safe after first trimester)
Treat infections (malaria prophylaxis/treatment)

Treatment by Severity:

Hb Level	Treatment
10-10.9 (Mild IDA)	Oral iron 200mg elemental/day (ferrous sulfate 200mg TDS), dietary counseling, IFA compliance
7-9.9 (Moderate IDA)	Oral iron (increase dose), consider IV iron if oral not tolerated
4-6.9 (Severe IDA) at ≥ 34 weeks	IV iron infusion, consider blood transfusion if symptomatic or near term
< 4 (Very severe)	Blood transfusion, manage cardiac failure, deliver at tertiary center

Oral Iron:

Ferrous sulfate 200mg (60mg elemental iron per tablet) - 2-3 times daily
Side effects: nausea, constipation, black stools, epigastric discomfort
Take on empty stomach for maximum absorption (but if intolerant, take with food)
Take with orange juice / vitamin C - enhances absorption
Avoid with tea, coffee, calcium, antacids

Intravenous Iron:

Indications:

Oral iron intolerance / non-compliance
Moderate-severe anemia after 34 weeks (insufficient time for oral therapy)
Malabsorption syndrome
When rapid correction needed (before delivery)

Preparations available in India:

Iron sucrose (Venofer) - 100-200mg over 15-30 min, repeated doses every 2-3 days - safest
Ferric carboxymaltose (Ferinject) - up to 1000mg as single dose - convenient
Low molecular weight iron dextran - less commonly used now

Target: Hb ≥ 10 g/dL before delivery

Blood Transfusion:

Indications:

Hb < 6 g/dL at any gestation
Hb < 8 g/dL with symptoms at term
Hb < 8 g/dL with cardiac failure
Ante/intrapartum hemorrhage with anemia
Labor with Hb < 8 g/dL - transfuse before delivery

Target pre-delivery Hb: ≥ 10 g/dL ideally

Megaloblastic Anemia (Folate Deficiency):

Folic acid 5 mg/day orally (therapeutic dose, not just prophylactic 400μg)
Continue through pregnancy

B12 Deficiency:

Hydroxycobalamin / Cyanocobalamin 1000μg IM injection
Oral B12 supplementation for mild cases

Intrapartum Management:

Active management of third stage (oxytocin immediately after delivery)
Minimize blood loss
Avoid anemia-worsening procedures
Cross-match blood if Hb < 8 g/dL

Postpartum:

Continue oral iron for 3 months postpartum
Encourage interpregnancy interval ≥ 2 years
Treat underlying causes (deworming, malaria)

PART 9 - VIVA QUESTIONS AND ANSWERS

Q1. Define anemia in pregnancy. Why is the threshold different from non-pregnant women? A: Anemia in pregnancy is defined as Hb < 11 g/dL in the first and third trimester, and < 10.5 g/dL in the second trimester (WHO). In non-pregnant women, the threshold is < 12 g/dL. The lower threshold in pregnancy accounts for the normal physiologic hemodilution - plasma volume increases 47% while RBC mass increases only 17%, creating a dilutional fall in Hb. This is normal and protective (improved uteroplacental perfusion). True anemia in pregnancy means iron/folate/B12 stores are insufficient even for this expanded RBC mass.

Q2. What is the most common cause of anemia in pregnancy in India? A: Iron Deficiency Anemia (IDA) accounts for over 80% of anemia in pregnancy in India. This is primarily due to: pre-pregnancy iron depletion (poor diet, menorrhagia), inadequate iron intake during pregnancy (vegetarian diet, poverty), increased iron demand of pregnancy (~1000 mg total), poor IFA compliance, and hookworm infestation causing chronic occult blood loss.

Q3. What is the most sensitive test for diagnosing iron deficiency in pregnancy? A: Serum ferritin is the most sensitive and specific test. It reflects total body iron stores - it falls first even before serum iron, MCHC, or Hb change. A ferritin < 20 μg/L indicates depleted stores; < 12 μg/L indicates severe depletion. However, ferritin is an acute phase reactant - it may be falsely elevated in infection/inflammation, masking true deficiency. In such cases, soluble transferrin receptor (sTfR) level is more reliable.

Q4. How do you differentiate IDA from thalassemia trait on blood counts? A: Both cause microcytic hypochromic anemia. Key differences:

Ferritin: Low in IDA, normal/high in thalassemia trait
RBC count: Low in IDA, HIGH in thalassemia trait (very characteristic)
RDW: High in IDA (anisocytosis), normal in thalassemia trait
Mentzer Index (MCV/RBC): > 13 = IDA; < 13 = thalassemia trait
Hb Electrophoresis: HbA2 > 3.5% confirms beta thalassemia trait
Response to iron: IDA improves; thalassemia trait does not

Q5. What is the significance of identifying thalassemia trait in pregnancy? A: If the mother has thalassemia trait, the partner must be tested. If both parents are carriers (beta thal trait): 25% risk of thalassemia major in baby. Thalassemia major (transfusion-dependent) is a devastating disease. Prenatal diagnosis by chorionic villus sampling (CVS) at 10-12 weeks or amniocentesis at 15-18 weeks should be offered. Termination of an affected fetus may be considered.

Q6. How does hookworm cause anemia? A: Hookworms (Ancylostoma duodenale, Necator americanus) attach to the intestinal mucosa and suck blood. Each worm causes 0.03-0.2 mL blood loss per day. A heavy worm burden (hundreds of worms) can cause significant chronic iron-deficiency anemia through occult gastrointestinal blood loss. Treatment: Albendazole 400mg single dose (safe after first trimester). Always test stool for ova in pregnant women with IDA.

Q7. What is the role of IV iron in pregnancy? What are its advantages? A: IV iron bypasses gut absorption issues, provides rapid correction, and is especially useful when: oral iron is not tolerated, Hb needs rapid correction before delivery (<34 weeks), malabsorption is present. Iron sucrose (safest profile) and ferric carboxymaltose (single large dose) are commonly used. IV iron raises Hb faster than oral iron (results in 2-4 weeks vs 6-8 weeks for oral). Anaphylaxis risk is very low with iron sucrose and ferric carboxymaltose (higher with iron dextran - test dose required).

Q8. When is blood transfusion indicated in anemia in pregnancy? A: Indications include: Hb < 6 g/dL at any gestation, symptomatic anemia (cardiac failure, severe dyspnea at rest) even at higher Hb, Hb < 8 g/dL at/near term with inadequate time for medical correction, intrapartum anemia with active bleeding. Target pre-delivery Hb ≥ 10 g/dL. Each unit of packed red cells raises Hb by approximately 1 g/dL. Furosemide should be co-administered to prevent fluid overload.

Q9. What is the role of folic acid in preventing neural tube defects? A: Folic acid is essential for DNA synthesis and rapidly dividing cells. The neural tube closes at 28 days of gestation - before many women even know they are pregnant. Folic acid 400 μg/day (or 5 mg/day if high-risk: previous NTD baby, anticonvulsant therapy, diabetes) should be started PRECONCEPTIONALLY (at least 1 month before conception) and continued through the first 12 weeks. The National Nutrition Policy in India mandates folic acid supplementation for all pregnant women. Periconceptional folic acid reduces NTD risk by 70%.

Q10. What is the effect of anemia on the fetus? A: Mild anemia has minimal fetal effect. Moderate-severe anemia causes: IUGR (uteroplacental insufficiency), preterm birth (hypoxia stimulates uterine contractions), low birth weight, fetal distress during labor (reduced oxygen reserve), neonatal anemia and reduced iron stores. Long-term effects on the infant include impaired cognitive development, poor brain myelination, and developmental delay due to neonatal iron deficiency.

Q11. What is "dangerous anemia" in pregnancy? A: Hemoglobin < 4 g/dL is called dangerous/very severe anemia. At this level: resting cardiac output is massively elevated (high-output state), the heart cannot compensate further → cardiac failure, pulmonary edema. Risk of maternal death is very high. Immediate blood transfusion is mandatory. Delivered at tertiary center with ICU backup. Packed cells are given slowly with diuretic cover to prevent fluid overload.

Q12. What are the National Nutritional Anemia Control Programme recommendations for IFA supplementation? A: Under India's NTCP/ANCP: All pregnant women receive 1 IFA tablet daily (containing 100mg elemental iron + 500μg folic acid) from first trimester, for a minimum of 100 days. High-risk women (Hb < 8 g/dL) receive 2 tablets per day. The program has also shifted to weekly supplementation for adolescent girls as prevention strategy. Iron deficiency is the most preventable cause of maternal mortality in India.

Ready for the Next Case!

That completes Long Case 2: Anemia Complicating Pregnancy.

Say "next" for Long Case 3: Rh-Negative Pregnancy (Isoimmunization / Rh Incompatibility).

Finding Sources

Reading File

Finding Sources

Reading File

I have sufficient reference material. Here is Long Case 3:

LONG CASE 3: Rh-NEGATIVE PREGNANCY (Rh ISOIMMUNIZATION)

PART 1 - CASE SHEET (PROFORMA)

OBSTETRIC CASE SHEET - Rh-NEGATIVE PREGNANCY

Date: _____________ IP No: _____________ Ward: _____________

A. PERSONAL DETAILS


Name
Age
G P L A
Blood Group (Patient)	(e.g., O Rh-negative)
Blood Group (Husband)	(e.g., A Rh-positive)
Address
Socioeconomic status

B. CHIEF COMPLAINTS

Routine ANC visit / Incidentally detected Rh-negative blood group
Decreased fetal movements since _____
Abdominal distension (polyhydramnios) since _____
Reduced uterine growth
Baby looking pale/jaundiced at birth (if postpartum)
Previous bad obstetric history (stillbirth / neonatal death / neonatal jaundice)

C. HISTORY OF PRESENT ILLNESS

When was Rh-negative status first detected?
Was anti-D prophylaxis given in past pregnancies?
Indirect Coombs Test (ICT) result - negative (unsensitized) or positive (sensitized)
If ICT positive: antibody titer level and trend
USG findings: fetal hydrops, MCA Doppler result, AFI
Any fetal movements - normal / decreased / absent

D. OBSTETRIC HISTORY

Present Pregnancy:

LMP: _________ EDD: _________
POG: _____ weeks
Booking status: Booked / Unbooked
Previous ICT reports during this pregnancy
Sensitizing events during this pregnancy: bleeding, amniocentesis, trauma
USG with MCA Doppler findings

Previous Obstetric History (CRITICAL):

Preg	Year	POG	Delivery	Sex	BW	Outcome	Anti-D given?	Rh of baby	Jaundice?
1
2
3

Ask specifically:

Any previous abortion / ectopic / molar pregnancy - was anti-D given?
Any previous stillbirth / IUD - was it caused by Rh incompatibility?
Any previous neonatal death due to jaundice/anemia/hydrops?
Any previous baby who required exchange transfusion or phototherapy?
Any previous blood transfusion (pre-pregnancy) - was it Rh-matched?

E. MEDICAL & SURGICAL HISTORY

Blood transfusion: was it Rh-positive blood given to Rh-negative woman?
Any uterine procedures: D&C, MVA, CVS, amniocentesis (sensitizing procedures)
Previous abdominal trauma

F. FAMILY HISTORY

Rh blood group of family members (not directly relevant but may provide context)

G. PERSONAL HISTORY

Diet, habits (standard enquiry)

H. GENERAL EXAMINATION

Parameter	Finding
General condition
Pallor	(maternal pallor - not directly related)
Icterus	(usually not present in mother)
BP
Pulse
Edema

I. OBSTETRIC EXAMINATION

Inspection:

Abdomen: larger than dates? (polyhydramnios - excess liquor due to fetal hydrops)
Scars

Palpation:

Fundal height: corresponds to POG / larger than dates (polyhydramnios)
Lie, presentation, position
Liquor: increased (polyhydramnios - fetal hydrops)
Skin of fetal scalp (if presenting - edematous in hydrops)

Auscultation:

FHR: normal / tachycardia (fetal anemia) / absent (IUD)

J. INVESTIGATIONS

Investigation	Result	Significance
Blood group & Rh (Mother)		Rh-negative confirmed
Blood group & Rh (Father)		Rh-positive = risk; Rh-negative = no risk
Indirect Coombs Test (ICT)	Negative / Positive	Sensitization status
Antibody titer (if ICT positive)	1:___	Titer ≥1:16 = significant
CBC (Mother)
Urine routine
USG abdomen (obstetric)
MCA Doppler (Peak Systolic Velocity)	cm/sec	>1.5 MoM = fetal anemia
AFI		Polyhydramnios in hydrops
BPP
CTG
Fetal blood group (if needed)		Via amniocentesis / cell-free fetal DNA

PART 2 - PRESENTATION WITH "WHY" OF EVERY HISTORY

WHY we ask each question - Rationale

Blood Group of Patient and Husband

Why ask? This is the cornerstone of the entire case. For Rh isoimmunization to occur, the mother must be Rh-negative (lacks D antigen) and the fetus must be Rh-positive (inherits D antigen from Rh-positive father). If the father is also Rh-negative, the fetus will always be Rh-negative and there is NO risk of isoimmunization.

Father's Rh Type - Homozygous or Heterozygous?

Why ask? If the father is Rh-positive, determine if he is homozygous (DD - all children will be Rh-positive, 100% risk) or heterozygous (Dd - 50% of children will be Rh-positive, 50% Rh-negative). This determines the probability of the current fetus being affected.

Obstetric History - Were Previous Babies Rh-positive?

Why ask? Confirms isoimmunization occurred. A history of neonatal jaundice, exchange transfusion, or fetal hydrops/IUD in previous pregnancies strongly suggests established Rh isoimmunization. The disease worsens with each successive Rh-positive pregnancy.

Anti-D Given in Previous Pregnancies?

Why ask? Anti-D (Rh immunoglobulin) prevents sensitization by clearing fetal Rh-positive cells from maternal circulation before the immune response can develop. If anti-D was NOT given after previous deliveries, abortions, or sensitizing events, the mother is highly likely to be sensitized. This is the most preventable cause of Rh disease.

Previous Abortions / Ectopic / Molar Pregnancy + Anti-D Given?

Why ask? Feto-maternal hemorrhage can occur even with first trimester events (abortion >8 weeks, D&C, CVS). If anti-D was not given after these events, sensitization could have occurred. Even 50 μg anti-D is sufficient after first trimester events (250 IU).

Previous Stillbirth / Neonatal Death / Hydrops

Why ask? These are the tragic outcomes of untreated Rh disease. A history of unexplained stillbirth, severely jaundiced newborn, or neonatal death from anemia points toward past Rh disease. Each successive Rh-positive pregnancy causes earlier and more severe fetal anemia.

Previous Blood Transfusion

Why ask? If an Rh-negative woman received Rh-positive blood transfusion (even once, years before pregnancy), she may be sensitized. This is an important iatrogenic cause of Rh isoimmunization. Requires as little as 1 mL of Rh-positive blood to sensitize.

Amniocentesis / CVS / External Cephalic Version (ECV) during this Pregnancy

Why ask? These procedures cause feto-maternal hemorrhage and are potent sensitizing events. Anti-D must be given within 72 hours of each of these procedures. If it was not given, sensitization may have occurred even if the patient was previously unsensitized.

Decreased Fetal Movements

Why ask? In Rh-sensitized pregnancies, the fetus develops progressive hemolytic anemia. Severe fetal anemia leads to: tissue hypoxia → cardiac failure → fetal hydrops → fetal death. Reduced fetal movements are an early sign of fetal compromise (fetal hypoxia reduces activity). Requires immediate assessment with MCA Doppler.

Abdominal Distension / Larger than Dates

Why ask? Polyhydramnios (excess amniotic fluid) is a sign of fetal hydrops - the hydropic fetus has reduced swallowing (neuromuscular compromise) and increased fetal urine output due to cardiac failure, causing excess liquor. Clinically, the uterus is larger than dates, tense, and fluid thrill is positive.

ICT (Indirect Coombs Test) Result

Why ask? ICT detects anti-D antibodies in maternal serum. Negative ICT = unsensitized (prophylaxis still effective). Positive ICT = sensitized (prophylaxis no longer useful, monitoring and treatment required). Titer quantification determines severity and guides management.

Gestational Age at Onset of Symptoms (or Hydrops Detection)

Why ask? Earlier onset of hydrops = more severe disease. Hydrops before 24 weeks carries the worst prognosis. This is also called "Liley's rule" - earlier the affection, more severe the outcome. Gestational age also determines feasibility of intrauterine transfusion vs early delivery.

PART 3 - CAUSES AND DIFFERENTIAL DIAGNOSIS

Classification of Rh Incompatibility:

Sensitized vs Unsensitized Rh-Negative Pregnancy

Category	ICT	Antibody Titer	Management
Unsensitized	Negative	Nil	Anti-D prophylaxis at 28 wks + delivery
Sensitized (mild)	Positive	1:8 or less	Serial titer, USG, MCA Doppler monitoring
Sensitized (significant)	Positive	1:16 or more	MCA Doppler weekly, consider fetal blood sampling
Sensitized (severe/hydrops)	Positive	High	Intrauterine transfusion / early delivery

Rh System - Key Antigens:

The Rh (CDE) system has >50 antigens; D antigen is the most immunogenic
Even 1 mL of Rh-positive blood into an Rh-negative person can sensitize
Other clinically significant antigens: c, E, Kell (K), Duffy (Fy), Kidd (Jk) - can also cause HDFN

Differential Diagnosis of Hydrops Fetalis:

Type	Cause	Features
Immune hydrops	Rh/Kell/ABO isoimmunization (10-20% of hydrops)	ICT positive, maternal antibodies
Non-immune hydrops (NIHF)	Most common today (80-90% of hydrops)	ICT negative
- Cardiovascular	Structural heart defects, arrhythmias	Fetal echo abnormal
- Chromosomal	Turner's (45X), trisomy 21/18/13	Karyotype abnormal
- Hematological	Alpha thalassemia major (Hb Barts)	Hb electrophoresis
- Infections	Parvovirus B19, CMV, Toxoplasma	TORCH screen positive
- Lymphatic	Cystic hygroma, lymphangiectasia	USG neck/chest
- Metabolic	Storage disorders	Enzyme assays
- Twin-twin transfusion	Monochorionic twins	USG diamniotic/monochorionic

Key point for exam: Non-immune hydrops has largely replaced immune hydrops as the most common cause, thanks to anti-D prophylaxis.

PART 4 - SUMMARY OF POSITIVE FINDINGS

Model Summary Statement:

"Mrs. _____, a ___-year-old gravida _____, para _____, blood group O Rh-negative, with a period of gestation of _____ weeks, presented for routine ANC / with complaints of decreased fetal movements / with a previous history of stillbirth / neonatal jaundice.

Her husband's blood group is _____ Rh-positive. She had a previous abortion / delivery in ____ year for which anti-D was / was not administered.

Indirect Coombs Test (ICT) is negative (unsensitized) / positive with a titer of 1:___.

On obstetric examination, the uterus is _____ weeks size, corresponding to / larger than dates. Fetal heart sounds are heard / not heard at _____ bpm. USG shows AFI of _____ with / without features of fetal hydrops. MCA peak systolic velocity is _____ cm/sec (_____ MoM).

A diagnosis of Rh-negative pregnancy, unsensitized / sensitized (ICT titer 1:___) at _____ weeks of gestation with / without fetal hydrops is made."

PART 5 - EXAMINATION PROCEDURE

Step-by-Step Clinical Examination

Step 1: Confirm Blood Group Card

Ask patient to show blood group card (every Rh-negative woman should carry one)
Confirm: Rh-negative status

Step 2: General Examination

Pallor (maternal - usually absent)
Jaundice (NOT expected in mother - icterus is in the BABY)
Vital signs
Edema (not directly related to Rh disease)

Step 3: Obstetric Examination - Inspect Abdomen

Size: Is it larger than expected for POG? (Polyhydramnios suggests hydrops)
Shape: Ovoid (normal), globular, tense (polyhydramnios)

Step 4: Palpate Abdomen (Leopold's Maneuvers)

Fundal height measurement: Measure in cm
- Larger than dates by >4 cm suggests polyhydramnios
Fundal grip: Head / Breech at fundus
Lateral grip: Back position
Pelvic grip: Presenting part - ballotable (floating due to polyhydramnios) / engaged
Fluid thrill test: One hand on one side taps the abdomen; wave felt on other side = positive fluid thrill (severe polyhydramnios)
Shifting dullness: Assess for ascites (a component of fetal hydrops in the mother is NOT expected - remember hydrops is fetal, not maternal)

Step 5: Auscultation

FHR: Tachycardia (>160/min) may suggest fetal anemia/distress
If FHS absent: IUFD (worst outcome)

Step 6: Special Tests to Mention in Examination

Indirect Coombs Test (ICT): The KEY investigation
- Patient's serum + Rh-positive test cells → anti-human globulin added → if agglutination = ICT positive
MCA Doppler (Middle Cerebral Artery):
- Non-invasive gold standard for fetal anemia detection
- Measure Peak Systolic Velocity (PSV) of MCA
- PSV > 1.5 MoM (multiples of median) = significant fetal anemia → intervene
- Rationale: Anemic fetus increases cardiac output + blood becomes less viscous → faster blood flow in MCA
Kleihauer-Betke Test: Detects and quantifies fetal cells in maternal blood (to estimate degree of feto-maternal hemorrhage and calculate required anti-D dose)

PART 6 - DIAGNOSIS WITH EXPLANATION

Diagnostic Framework

Case Type A: Unsensitized Rh-Negative Pregnancy

Blood group: Mother Rh-negative, Father Rh-positive
ICT: Negative (no antibodies formed yet)
Significance: Still at risk - prophylaxis is the priority
Management: Anti-D immunoglobulin protocol + serial ICT monitoring

Case Type B: Sensitized Rh-Negative Pregnancy (ICT Positive)

ICT positive → confirm with antibody identification (it IS anti-D)
Titer determination: Quantitative ICT
- Titer < 1:8 = mild (serial monitoring)
- Titer ≥ 1:16 = critical titer (significant risk of fetal anemia)
- Rising titer with each pregnancy indicates progressive disease

Case Type C: Rh Sensitization with Fetal Hydrops

ICT positive + high titer + USG features of hydrops
Features of hydrops on USG: ascites, pleural effusion, pericardial effusion, skin edema (>5mm), placentomegaly (thick placenta >6cm)
MCA PSV > 1.5 MoM confirms severe fetal anemia

Pathophysiology (Why Disease Worsens with Each Pregnancy):

First Rh-positive pregnancy: Feto-maternal hemorrhage (usually at delivery) → Rh-positive fetal RBCs enter maternal circulation → Primary IgM response (slow, does not cross placenta) → First baby usually unaffected
Second Rh-positive pregnancy: Prior memory B cells exist → Rapid IgG response to even small fetal bleed → Anti-D IgG crosses placenta → Binds to fetal Rh-positive RBCs → Complement activation + splenic macrophage phagocytosis → Fetal hemolysis
Third and subsequent pregnancies: Earlier onset, more severe hemolysis, hydrops may develop by mid-trimester

Source: Robbins Pathologic Basis of Disease - "The initial exposure to Rh antigen evokes IgM antibodies that do not cross the placenta. Exposure during a subsequent pregnancy leads to a brisk IgG antibody response and risk of immune hydrops."

ABO Incompatibility vs Rh Incompatibility:

Feature	Rh Incompatibility	ABO Incompatibility
First pregnancy	Usually unaffected	Can affect first baby
Severity	Progressive with each pregnancy	Mild, rarely severe
Antibody type	IgG (crosses placenta)	Mainly IgM (does NOT cross)
Prevention	Anti-D prophylaxis	No effective prophylaxis
Hydrops	Can occur	Extremely rare
Jaundice severity	Severe	Mild-moderate
Direct Coombs (baby)	Strongly positive	Weakly positive

PART 7 - CASE DISCUSSION

Key Discussion Points

1. The Rh Blood Group System

Determined by genes on chromosome 1
D antigen is most immunogenic (absence = Rh-negative)
D antigen expression is all-or-none (unlike ABO)
Rh-negative frequency: 5-15% in Indian population (higher in Caucasians ~15%), lower in Asians (~1%)
If father is heterozygous (Dd), 50% risk of Rh-positive fetus

2. Sensitizing Events in Pregnancy

Any event causing feto-maternal hemorrhage can sensitize an Rh-negative woman:

Event	Minimum Anti-D dose
First trimester abortion (<12 wks)	50 μg (250 IU)
First trimester events: CVS, ectopic	50 μg (250 IU)
Second/third trimester: amniocentesis, antepartum hemorrhage, ECV, trauma	300 μg (1500 IU)
Delivery (if baby is Rh-positive)	300 μg (1500 IU) - within 72 hrs
Antenatal prophylaxis (28 weeks)	300 μg (1500 IU)

3. Consequences of Fetal Hemolysis

Step 1: Maternal anti-D IgG crosses placenta → coats fetal RBCs Step 2: Fetal RBCs destroyed by spleen (extravascular hemolysis) → fetal anemia Step 3: Fetal bone marrow + extramedullary hematopoiesis (liver, spleen) try to compensate → erythroblasts in blood (hence "erythroblastosis fetalis") Step 4: Severe anemia → tissue hypoxia → cardiac failure → hypoproteinemia (liver damage) → hydrops fetalis Step 5: Bilirubin (from hemolysis): in utero - cleared by placenta (not a fetal problem), but after birth - fetal liver cannot conjugate rapidly → hyperbilirubinemia → kernicterus (bilirubin deposits in basal ganglia → permanent brain damage)

4. Hydrops Fetalis

Definition: Abnormal accumulation of fluid in ≥2 fetal compartments (ascites, pleural effusion, pericardial effusion, skin edema) Mechanism: Severe anemia → cardiac failure + hypoalbuminemia (damaged fetal liver) → low oncotic pressure → fluid leaks out Prognosis: Without treatment, almost universally fatal

5. Delta OD 450 (Liley's Chart) - Historical

Before MCA Doppler: amniotic fluid bilirubin measured by spectrophotometry at 450nm
Plotted on Liley's chart (3 zones): Zone I = mild, Zone II = moderate, Zone III = severe
Now largely replaced by MCA Doppler (non-invasive, equally accurate)

6. Intrauterine Transfusion (IUT)

Intravascular transfusion via umbilical vein (cordocentesis/PUBS - Percutaneous Umbilical Blood Sampling)
Indicated when MCA PSV > 1.5 MoM and fetus too immature to deliver
O-negative, CMV-negative, irradiated, leukoreduced packed cells used
Target post-transfusion hematocrit: 40-50%
Can be repeated every 2-3 weeks
Corrects anemia, treats hydrops, buys time until maturity

PART 8 - INVESTIGATIONS AND MANAGEMENT

Investigations

At Booking (First Visit):

Blood group and Rh type (mother)
Indirect Coombs Test (ICT) - if Rh-negative
Blood group and Rh type (father/husband)
Fetal Rh typing (cell-free fetal DNA from maternal blood - if father Rh-positive and homozygous status unknown)

Monitoring in Unsensitized Rh-Negative Pregnancy:

ICT at booking, 28 weeks, and delivery
If ICT remains negative throughout: prophylaxis at 28 weeks, and after delivery if baby Rh-positive

Monitoring in Sensitized Rh-Negative Pregnancy (ICT Positive):

Quantitative antibody titer (serial, every 2-4 weeks)
USG with biometry: fetal growth, placental thickness, AFI
MCA Doppler (PSV) - weekly from 18-20 weeks onward:
- PSV < 1.5 MoM: continue monitoring
- PSV > 1.5 MoM: significant anemia → fetal blood sampling / IUT
CTG / BPP: fetal well-being assessment
If hydrops suspected: Detailed anomaly scan, echocardiography
Cordocentesis (PUBS): Fetal blood sampling - for hemoglobin, blood group, Coombs, reticulocyte count; also route for IUT

Management

A. Unsensitized Rh-Negative Pregnancy (ICT Negative)

Prophylactic Anti-D Immunoglobulin Protocol:

Timing	Dose
28 weeks antenatal	300 μg (1500 IU) IM
After delivery (if baby Rh-positive, within 72 hours)	300 μg (1500 IU) IM
After any sensitizing event (amniocentesis, APH, ECV, abortion)	300 μg (1500 IU) IM
After first trimester events (<12 wks)	50 μg (250 IU) IM

Why within 72 hours? Anti-D works by clearing Rh-positive fetal cells from maternal circulation before the primary immune response is established. After 72 hours, the immune response may already have begun - anti-D is less effective (though still given up to 10-14 days in some guidelines).

Kleihauer-Betke test: If large feto-maternal hemorrhage suspected (antepartum hemorrhage, traumatic delivery) - test maternal blood to quantify fetal cells and calculate exact anti-D dose needed.

B. Sensitized Rh-Negative Pregnancy (ICT Positive)

Note: Anti-D prophylaxis is USELESS once sensitized (immune response already established).

Management depends on:

Antibody titer
MCA PSV MoM
Gestational age
Presence of hydrops

Situation	Action
Titer < 1:8, PSV < 1.5 MoM	Serial monitoring every 2-4 weeks
Titer ≥ 1:16 OR PSV > 1.5 MoM, ≥ 34 weeks	Deliver
Titer ≥ 1:16 OR PSV > 1.5 MoM, < 34 weeks	Fetal blood sampling → IUT if anemic
Hydrops present, ≥ 34 weeks	Deliver immediately
Hydrops present, < 34 weeks	IUT + steroids for lung maturity + deliver at 34 wks
IUFD	Deliver, counsel, prevent in next pregnancy

C. Neonatal Management (by Pediatricians)

Cord blood: blood group, Coombs, Hb, bilirubin
Phototherapy: for hyperbilirubinemia
Exchange transfusion: if bilirubin rapidly rising / kernicterus risk (O-negative blood used)
IVIG (intravenous immunoglobulin): reduces hemolysis in HDN
Top-up transfusion: for neonatal anemia

D. Mode and Timing of Delivery

Unsensitized: Allow labor at term; LSCS only for obstetric indication
Sensitized, stable: Deliver at 37-38 weeks (vaginal/LSCS per obstetric need)
Hydrops: Deliver at 34 weeks or earlier if worsening; LSCS usually preferred
Intrapartum: Continuous CTG; avoid traumatic delivery; cord blood sample immediately at delivery

PART 9 - VIVA QUESTIONS AND ANSWERS

Q1. What is Rh isoimmunization? How does it develop? A: Rh isoimmunization is the process whereby an Rh-negative mother develops anti-D IgG antibodies after exposure to Rh-positive fetal red blood cells (feto-maternal hemorrhage). First exposure → primary IgM response (harmless, does not cross placenta). Subsequent Rh-positive pregnancy → rapid secondary IgG response → anti-D IgG crosses placenta → attaches to fetal Rh-positive RBCs → fetal hemolysis → hemolytic disease of the fetus and newborn (HDFN).

Q2. Why is the first baby usually unaffected in Rh incompatibility? A: Because the first feto-maternal hemorrhage (usually at delivery) stimulates a primary immune response producing IgM antibodies - these are large molecules that cannot cross the placenta. By the time significant IgG is produced, the baby is already born. Therefore, the first baby escapes the effects of isoimmunization. (Exception: if the mother was previously sensitized by blood transfusion or a previous unrecognized pregnancy loss.)

Q3. What is the Indirect Coombs Test (ICT)? How is it performed? A: The ICT detects antibodies in the mother's serum against red cell antigens. Method: (1) Patient's serum is incubated with Rh-positive test red cells → antibodies in serum attach to cells. (2) Anti-human globulin (Coombs serum) is added → if antibodies are present on cells, agglutination occurs = ICT positive (sensitized). ICT is the screening test for Rh isoimmunization. The Direct Coombs Test (DCT) detects antibodies already attached to the baby's RBCs (performed on cord blood).

Q4. What is the critical titer in Rh isoimmunization? A: The critical titer is 1:16 - at this level or above, there is significant risk of fetal anemia and hydrops. Titers of 1:8 or below are considered low risk. However, titer alone is unreliable (can remain stable even while fetus is developing severe anemia) - hence MCA Doppler PSV is now the gold standard for monitoring fetal anemia, not titer.

Q5. What is MCA Doppler and how is it used in Rh isoimmunization? A: MCA (Middle Cerebral Artery) Peak Systolic Velocity (PSV) Doppler is the non-invasive gold standard for detecting fetal anemia. In anemia: cardiac output increases (compensatory) + blood viscosity decreases → blood flows faster in MCA. PSV > 1.5 MoM (multiples of median for gestational age) = significant fetal anemia. It has replaced amniocentesis (delta OD450) and invasive fetal blood sampling as the first-line surveillance tool. Sensitivity ~88%, specificity ~82% for predicting moderate-severe fetal anemia.

Q6. When is anti-D prophylaxis indicated? What is the dose? A: Anti-D (Rh immunoglobulin) is given to all Rh-negative, unsensitized women:

28 weeks antenatal: 300 μg IM (covers sensitizing events up to delivery)
Within 72 hours of delivery of Rh-positive baby: 300 μg IM
After any sensitizing event: 300 μg IM (first trimester: 50 μg) Anti-D works by clearing fetal Rh-positive cells before a primary immune response develops (passive antibody-mediated immune suppression). It is USELESS once sensitization (ICT positive) has occurred.

Q7. What is hydrops fetalis? What are its USG features? A: Hydrops fetalis is the abnormal accumulation of fluid in ≥2 extravascular compartments of the fetus. USG features: fetal ascites, pleural effusion, pericardial effusion, skin/scalp edema (>5mm), placentomegaly (placenta >6cm thick), polyhydramnios. In Rh disease, the mechanism is: severe hemolytic anemia → fetal cardiac failure + hypoalbuminemia (from damaged fetal liver) → low oncotic pressure → fluid leakage. Without intrauterine transfusion, prognosis is almost universally fatal.

Q8. What is intrauterine transfusion (IUT)? When is it indicated? A: IUT is the transfusion of compatible blood directly into the fetus via the umbilical vein under ultrasound guidance (cordocentesis). Indication: MCA PSV > 1.5 MoM when gestational age is too early for safe delivery (<34 weeks). Blood used: O-negative, CMV-negative, irradiated (to prevent graft-vs-host disease), leukodepleted, packed to hematocrit 75-85%. Target post-transfusion hematocrit 40-50%. Can be repeated every 2-4 weeks. Complications: cord spasm, fetal bradycardia, bleeding, infection, preterm labor.

Q9. How does ABO incompatibility differ from Rh incompatibility? A: ABO incompatibility can affect the first baby (group O mothers may have preformed IgG anti-A/anti-B without prior sensitization). It causes mild jaundice but rarely hydrops. No effective prophylaxis exists. Rh incompatibility generally spares the first baby, worsens with successive pregnancies, can cause severe hydrops and death, but is largely preventable with anti-D prophylaxis. Direct Coombs in ABO is weakly positive vs strongly positive in Rh disease.

Q10. What is the Kleihauer-Betke test? A: The Kleihauer-Betke test detects fetal red cells in maternal blood. Principle: maternal blood smear treated with acid buffer - adult Hb (HbA) elutes from RBCs (ghost cells) while fetal Hb (HbF) is resistant to acid and stains pink. Fetal cells counted per 50 low-power fields → calculate volume of feto-maternal hemorrhage → determine if standard 300 μg anti-D is sufficient or if additional doses are needed. Used after suspected large feto-maternal hemorrhage (trauma, abruption, manual removal of placenta).

Q11. What is "protected first pregnancy" in relation to ABO group? A: If the Rh-positive fetus is also ABO-incompatible with the mother (e.g., baby is group A, mother is group O), anti-A IgM in the mother's blood rapidly destroys fetal RBCs that enter maternal circulation before they can stimulate Rh sensitization. This is called "ABO protection" - it reduces the risk of Rh sensitization in the first pregnancy by about 10-20%.

Q12. What counseling will you give an Rh-negative woman? A: (1) Explain that Rh-negative itself is not dangerous - the risk is only if the baby is Rh-positive and no prophylaxis is given. (2) Ensure husband's blood group is tested. (3) Anti-D injection at 28 weeks and within 72 hours of delivery is mandatory. (4) Anti-D must be given after every sensitizing event - abortion, amniocentesis, trauma, APH, ECV. (5) Carry blood group card at all times. (6) If sensitized in this pregnancy, the disease is manageable with monitoring and IUT if needed. (7) Genetic counseling if partner is heterozygous - 50% chance of Rh-negative baby (unaffected).

Ready for the Next Case!

That completes Long Case 3: Rh-Negative Pregnancy.

Say "next" for Long Case 4: Diabetes Complicating Pregnancy (Gestational Diabetes Mellitus / Pre-gestational Diabetes).

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

I have enough reference material. Here is Long Case 4:

LONG CASE 4: DIABETES COMPLICATING PREGNANCY

(Gestational Diabetes Mellitus / Pre-gestational Diabetes)

PART 1 - CASE SHEET (PROFORMA)

OBSTETRIC CASE SHEET - DIABETES IN PREGNANCY

Date: _____________ IP No: _____________ Ward: _____________

A. PERSONAL DETAILS


Name
Age
G P L A
Height	cm
Weight (pre-pregnancy)	kg
Current weight	kg
BMI	kg/m²
Socioeconomic status
Occupation

B. CHIEF COMPLAINTS

Polyuria (increased urination) since _____
Polydipsia (excessive thirst) since _____
Polyphagia (increased appetite) since _____
Weight gain excessive / poor since _____
Abdominal size larger than expected (polyhydramnios / macrosomia) since _____
Decreased fetal movements since _____
Recurrent vulvovaginal candidiasis
Referred for abnormal blood sugar / abnormal GCT result
Known diabetic - routine review

C. HISTORY OF PRESENT ILLNESS

Onset: sudden / gradual
Duration
Severity of symptoms
Treatment already started: diet control / oral hypoglycemics / insulin
Monitoring: home blood glucose monitoring frequency
Recent HbA1c value

D. OBSTETRIC HISTORY

Present Pregnancy:

LMP: _________ EDD: _________
POG: _____ weeks
Booking status: Booked / Unbooked
GCT / OGTT result (with values and date)
Previous blood sugar reports during ANC
USG: fetal growth, estimated fetal weight, AFI
Any anomaly scan findings (congenital malformations)
HbA1c at booking

Previous Obstetric History (CRITICAL for GDM):

Preg	Year	POG	Delivery	Sex	BW	Outcome	Complications
1
2

Ask specifically:

Previous macrosomic baby (birth weight > 4 kg)
Previous unexplained stillbirth / IUD
Previous baby with congenital malformations
Previous GDM - was it treated? did it resolve postpartum?
Previous polyhydramnios
Previous LSCS (for dystocia / CPD from macrosomic baby)
Previous neonatal death / neonatal jaundice / hypoglycemia

E. MENSTRUAL HISTORY

LMP: certain / uncertain
Irregular cycles (PCOS - risk factor for GDM)

F. MEDICAL & SURGICAL HISTORY

Known T1DM / T2DM: duration, control, complications (nephropathy, retinopathy, neuropathy, IHD)
Hypertension: coexisting / superimposed pre-eclampsia
PCOS (polycystic ovarian syndrome) - strong risk factor
Obesity (BMI > 30)
Hypothyroidism (associated with insulin resistance)
Recurrent UTI / candidiasis
Any medications: corticosteroids (cause hyperglycemia), antipsychotics

G. FAMILY HISTORY

Diabetes mellitus in first-degree relatives (parents, siblings) - STRONG risk factor
Family history of macrosomic babies
Early onset cardiovascular disease in family

H. PERSONAL HISTORY

Diet: high carbohydrate, sugary foods, fast food
Physical activity: sedentary lifestyle
Smoking / alcohol
Stress levels

I. GENERAL EXAMINATION

Parameter	Finding
General condition
BMI	kg/m² - Overweight >25, Obese >30
Pallor
Acanthosis nigricans	Dark, velvety skin folds at neck, axilla, groin (insulin resistance marker)
Hirsutism	(PCOS association)
BP	(pre-eclampsia association)
Pulse
Temperature	(infections common in DM)
Edema
Eyes	Diabetic retinopathy (if pre-gestational DM)
Feet	Peripheral neuropathy, diabetic ulcers (if pre-gestational DM)

J. SYSTEMIC EXAMINATION

Cardiovascular:

Ischemic heart disease assessment (pre-gestational DM with long duration)

Neurological:

Peripheral neuropathy: reduced vibration sense, pinprick sensation

Abdomen: Obstetric examination (below)

Fundoscopy: If pre-gestational diabetes - look for retinopathy

K. OBSTETRIC EXAMINATION

Inspection:

Abdomen: size larger than expected for dates? (macrosomia / polyhydramnios)
Striae, linea nigra

Palpation:

Fundal height: > expected for POG (macrosomia / polyhydramnios)
Fetal parts: large fetus, head may not be engaged (macrosomia + CPD risk)
Fluid thrill (polyhydramnios)
Fetal movements: reduced (fetal compromise in poorly controlled DM)

Auscultation:

FHR (fetal tachycardia / bradycardia - distress)

L. INVESTIGATIONS

Investigation	Result	Target/Normal
Fasting blood glucose	mg/dL	<92 mg/dL (ADA)
2-hr post-prandial glucose	mg/dL	<120 mg/dL
HbA1c	%	<6% in pregnancy (pre-conceptional target <6.5%)
75g OGTT (IADPSG criteria)	Fasting / 1hr / 2hr	<92 / <180 / <153 mg/dL
GCT (50g, 1hr)	mg/dL	<140 mg/dL (screening)
Urine for glucose
Urine for ketones
Urine routine / culture
CBC
Serum creatinine / BUN		(diabetic nephropathy)
Urine microalbumin		<30 mg/24hr
LFT
Thyroid profile (TSH)		(associated thyroid disease)
ECG		(IHD in pre-gestational DM)
USG abdomen	EFW, AFI, BPD, AC, FL	Macrosomia if EFW >4kg
Anomaly scan		Congenital malformations
CTG
Umbilical artery Doppler

PART 2 - PRESENTATION WITH "WHY" OF EVERY HISTORY

WHY we ask each question - Rationale

Age

Why ask? Advancing maternal age (>25-30 years) is associated with increasing insulin resistance and higher GDM risk. Older women also have higher prevalence of pre-existing T2DM. Teenage mothers are at lower risk unless obese or with PCOS.

BMI / Obesity

Why ask? Obesity (BMI ≥30) is the single strongest modifiable risk factor for GDM. Adipose tissue, especially visceral fat, produces adipokines (TNF-α, leptin, resistin) that impair insulin signaling. BMI ≥25 = overweight (increased risk); BMI ≥30 = obese (high risk). Pre-pregnancy weight counseling is therefore critical.

Polyuria, Polydipsia, Polyphagia (Classic Triad of DM)

Why ask? Hyperglycemia → osmotic diuresis → polyuria (>3 L/day) → dehydration → polydipsia (compensatory thirst). Polyphagia results from cellular glucose deficiency despite hyperglycemia (cells are starved despite high blood sugar). These symptoms indicate significant hyperglycemia (usually >180 mg/dL, above renal threshold).

Note: In GDM, the renal threshold for glucose is lowered in pregnancy, so glycosuria may appear even at normal blood sugars. Conversely, many GDM patients are completely asymptomatic - diagnosed only on screening.

Recurrent Vulvovaginal Candidiasis

Why ask? Hyperglycemia creates a glucose-rich environment in vaginal secretions that promotes Candida overgrowth. Recurrent candidiasis during pregnancy is a classic symptom suggestive of uncontrolled diabetes. Also associated with increased UTI risk.

Previous Macrosomic Baby (>4 kg)

Why ask? This is one of the strongest risk factors and retrospective indicators of GDM in previous pregnancies. Fetal macrosomia results from maternal hyperglycemia → fetal hyperglycemia → fetal hyperinsulinism → excessive growth. A woman who delivered a 4 kg or heavier baby should be screened early for GDM in the current pregnancy.

Previous Unexplained Stillbirth / IUD

Why ask? Unrecognized or poorly controlled diabetes in a previous pregnancy may have caused unexplained stillbirth. Diabetic fetopathy includes: metabolic crises (fetal hyperinsulinism + maternal hypoglycemia), chronic hypoxia (from placental dysfunction), or sudden unexpected fetal death (mechanism not fully understood but related to hyperglycemia). This history strongly prompts early and aggressive diabetes screening.

Previous Baby with Congenital Malformations

Why ask? Pre-gestational diabetes (especially if poorly controlled during the first 6-8 weeks - organogenesis period) causes congenital malformations due to teratogenic effect of hyperglycemia. HbA1c ≥10% in first trimester → 25% risk of major malformation. This history suggests the patient may have had undiagnosed pre-gestational DM.

Family History of Diabetes

Why ask? Type 2 DM and GDM have a strong genetic component. First-degree relatives with DM double or triple the risk of GDM. The disease involves polygenic inheritance of insulin secretion defects and insulin resistance traits.

PCOS History

Why ask? PCOS is characterized by insulin resistance (present in 70-80% of PCOS women) - the exact same pathophysiological mechanism as GDM. Women with PCOS have 2-3x higher risk of GDM. Metformin use pre-pregnancy for PCOS may need to be continued or replaced with insulin during pregnancy.

Gestational Age at Diagnosis

Why ask? GDM is usually diagnosed at 24-28 weeks (standard screening window). Early diagnosis (<24 weeks) suggests pre-gestational diabetes that was unrecognized, which carries higher teratogenicity risk (organogenesis is complete by 8-10 weeks). Women with risk factors should be screened at the first visit.

Previous GDM History

Why ask? Recurrence risk of GDM is 30-50%. Women with previous GDM also have 50-70% lifetime risk of developing T2DM. They should be screened at the first prenatal visit and again at 24-28 weeks if initial screen is negative.

Current Medications - Corticosteroids

Why ask? Corticosteroids (used for fetal lung maturity, autoimmune conditions) cause steroid-induced hyperglycemia - a well-recognized complication. Blood sugar monitoring and temporary insulin dose adjustment are required after steroid administration (especially antenatal betamethasone).

Fetal Movements

Why ask? In poorly controlled diabetes, the fetus is at risk of: chronic hypoxia (poor placental function), metabolic disturbances (fetal hyperinsulinism causing hypoglycemia in utero), and sudden unexpected fetal death. Reduced fetal movements are a warning sign requiring immediate CTG and BPP evaluation.

PART 3 - CAUSES AND DIFFERENTIAL DIAGNOSIS

Classification of Diabetes in Pregnancy

1. Pre-gestational Diabetes Mellitus

Type 1 DM in pregnancy: absolute insulin deficiency, ketosis-prone, requires insulin
Type 2 DM in pregnancy: insulin resistance + relative deficiency, may need dose escalation
Diagnosed BEFORE pregnancy or detected before 20 weeks of gestation

2. Gestational Diabetes Mellitus (GDM)

Glucose intolerance first detected DURING pregnancy (typically 24-28 weeks)
Resolves postpartum in most (but 50% risk of future T2DM)
White's Classification (historical, still asked): Classes A through R

Diagnostic Criteria (India: DIPSI / WHO / IADPSG):

DIPSI (Diabetes in Pregnancy Study Group India) - Most used in India:

Non-fasting 75g oral glucose → 2-hr venous plasma glucose
- ≥140 mg/dL = GDM (single test, non-fasting, any time of day)
- Practical, cost-effective, suitable for Indian settings

IADPSG / ADA (2010 onwards):

75g OGTT fasting (at 24-28 weeks)
GDM if ANY ONE of three values is met or exceeded:
- Fasting ≥ 92 mg/dL
- 1-hour ≥ 180 mg/dL
- 2-hour ≥ 153 mg/dL

Two-step approach (ACOG / USA):

Step 1: GCT (50g non-fasting, 1-hr) - cut-off ≥140 mg/dL (screen positive)
Step 2 (if positive): 100g OGTT (3-hr, fasting) - Carpenter-Coustan criteria
- Fasting ≥95, 1-hr ≥180, 2-hr ≥155, 3-hr ≥140 mg/dL
- GDM = 2 or more values met

Pre-gestational DM (diagnosis before/early pregnancy):

Fasting glucose ≥126 mg/dL
2-hr OGTT ≥200 mg/dL
Random glucose ≥200 mg/dL with symptoms
HbA1c ≥6.5%

Differential Diagnosis of Hyperglycemia in Pregnancy:

Condition	Key Features
GDM	First detected in pregnancy, typically 24-28 weeks, usually resolves postpartum
Pre-gestational T2DM	Known before pregnancy or high FBS/HbA1c at first visit, older/obese patient
Pre-gestational T1DM	Young, thin, ketosis-prone, absolute insulin dependence, autoantibodies
Steroid-induced hyperglycemia	After corticosteroid administration, transient, may need insulin
Gestational glycosuria	Reduced renal threshold in pregnancy, normal blood glucose
Transient hyperglycemia of stress	Acute illness/infection, resolves
MODY (Maturity-onset diabetes of the young)	Young, family history of early DM, mild fasting hyperglycemia

PART 4 - SUMMARY OF POSITIVE FINDINGS

Model Summary Statement:

"Mrs. _____, a ___-year-old gravida _____, para , with a period of gestation of _____ weeks, BMI _____ kg/m², with a previous history of macrosomic baby ( kg) / previous GDM / family history of DM, presented with complaints of polyuria, polydipsia, and a larger-than-dates uterus / referred for abnormal GCT result.

On general examination, she has acanthosis nigricans at the nape of neck. BP is _____ mmHg. BMI is _____ kg/m² (obese).

On obstetric examination, the uterus corresponds to _____ weeks, which is more than the gestational age of _____ weeks. Fetal parts are felt easily (polyhydramnios). Presenting part is mobile / not engaged (macrosomia with CPD).

USG shows estimated fetal weight of _____ g (macrosomia). AFI is _____ cm (polyhydramnios). GCT result is _____ mg/dL / OGTT values are Fasting _____, 1-hr _____, 2-hr _____ mg/dL, meeting the criteria for GDM. HbA1c is _____% .

A diagnosis of Gestational Diabetes Mellitus / Pre-gestational Diabetes complicating pregnancy at _____ weeks with fetal macrosomia / polyhydramnios is made."

PART 5 - EXAMINATION PROCEDURE

Step-by-Step Clinical Examination

Step 1: Assess BMI and Body Habitus

Measure height and current weight
Calculate BMI = weight(kg) / height²(m²)
Note central adiposity (waist circumference, apple body shape)

Step 2: Look for Signs of Insulin Resistance

Acanthosis nigricans: Dark, velvety, hyperpigmented skin in skin folds - neck (nape/sides), axilla, groin, under breasts. Classic marker of insulin resistance
Skin tags (acrochordons): Multiple small soft skin tags - associated with insulin resistance
Hirsutism: Excess facial/body hair (PCOS association)
Striae: Excessive weight gain

Step 3: Look for Complications of Pre-existing DM

Eyes: Fundoscopy - background retinopathy (dot hemorrhages, microaneurysms), proliferative retinopathy
Feet/Lower limbs:
- Peripheral neuropathy (loss of vibration sense with 128Hz tuning fork, monofilament test)
- Loss of ankle jerk
- Trophic changes, calluses, ulcers
Kidneys (indirect): Hypertension, edema (nephropathy)
Cardiovascular: Blood pressure, apex beat, peripheral pulses

Step 4: Vital Signs

BP: Pre-eclampsia (diabetes increases risk 3-4x)
Temperature: infections common
Pulse: tachycardia in DKA

Step 5: Obstetric Examination

Inspection:

Abdomen larger than dates? (macrosomia / polyhydramnios)
Excessive skin striae (rapid growth)

Palpation:

Fundal height: More than expected for POG by >4 cm = macrosomia or polyhydramnios
Leopold's Maneuvers:
- Fundal grip: Breech / Head at fundus - large, difficult to delineate fetal parts (macrosomia)
- Lateral grip: Back position - may be hard to identify (excess fluid)
- Pelvic grip: Head - is it engaged? (In macrosomia, head often NOT engaged = 5/5 palpable above brim → risk of CPD / shoulder dystocia)
- Fluid thrill: Tap one side, feel fluid wave on other side = positive (polyhydramnios)
Abdominal Circumference: Clinically and on USG - AC >95th percentile = macrosomia

Auscultation:

FHR: Tachycardia (>160) may suggest fetal distress (chronic hypoxia in diabetic pregnancy)

Step 6: Assessment of Fetal Wellbeing

Daily fetal movement count
CTG - reactive/non-reactive
BPP on USG
MCA Doppler + umbilical artery Doppler

PART 6 - DIAGNOSIS WITH EXPLANATION

Pathophysiology - WHY Does Diabetes Develop in Pregnancy?

Normal pregnancy physiology:

First trimester: Increased insulin sensitivity (hypoglycemia risk in early T1DM)
Second trimester onwards: Progressive insulin resistance develops (peaks at 26-28 weeks)
Cause: Placental hormones - human placental lactogen (hPL), progesterone, cortisol, prolactin → all are counter-regulatory (anti-insulin) hormones
hPL is the most important diabetogenic hormone of pregnancy
Normal pancreas compensates by increasing insulin secretion 3-4x
In susceptible women (pre-existing beta-cell dysfunction + genetic predisposition): pancreas cannot compensate → GDM develops

Harrison's: "Pregnancy is associated with marked insulin resistance; the increased insulin requirements often precipitate DM and lead to the diagnosis of GDM."

Why Hyperglycemia Harms the Fetus:

Glucose crosses placenta freely (facilitated diffusion)
Fetal hyperglycemia → fetal pancreatic beta cell stimulation → fetal hyperinsulinism
Insulin is the major fetal growth hormone → macrosomia (especially abdominal fat + muscle = asymmetric macrosomia)
Fetal hyperinsulinism also causes: polyhydramnios (polyuria), organomegaly, polycythemia
After birth: maternal glucose supply stops → neonatal hyperinsulinism persists briefly → neonatal hypoglycemia

Diabetic Fetopathy - "Infant of a Diabetic Mother (IDM)":

Feature	Mechanism
Macrosomia	Fetal hyperinsulinism → excess fat/muscle deposition
Polyhydramnios	Fetal polyuria (osmotic diuresis)
Organomegaly	Liver, heart, spleen enlarged
Cardiomegaly / HCM	Glycogen deposition in cardiac muscle
Polycythemia	Increased EPO (hypoxia) → excess RBCs
Jaundice	Polycythemia → excess bilirubin from RBC breakdown
Neonatal hypoglycemia	Hyperinsulinism persists after birth, maternal glucose withdrawn
RDS (respiratory distress)	Insulin inhibits surfactant synthesis (delayed lung maturity)
Congenital malformations	Hyperglycemia during organogenesis (teratogenic)

Most Common Congenital Malformations in Pre-gestational DM:

System	Malformation
Cardiac (most common)	VSD, TGA, ASD, coarctation of aorta
Neural tube	Anencephaly, spina bifida, holoprosencephaly
Skeletal	Caudal regression syndrome (PATHOGNOMONIC - sacral agenesis)
Renal	Renal agenesis, duplex kidney
GI	Duodenal atresia, Hirschsprung disease

Caudal regression syndrome (sacral/lumbar agenesis) is pathognomonic of diabetic embryopathy - seen 200-400x more commonly in IDM than general population.

PART 7 - CASE DISCUSSION

Key Discussion Points

1. Why Screen ALL Pregnant Women for GDM?

India has the highest prevalence of GDM in the world (10-15% of pregnancies). GDM is asymptomatic in most cases. Untreated GDM causes macrosomia, birth trauma, neonatal hypoglycemia, perinatal death, and future T2DM in mother and offspring. Universal screening (DIPSI protocol) is recommended by MoHFW India.

2. Glucose Targets in Pregnancy (Stricter than Non-pregnant)

Parameter	Target
Fasting blood glucose	<95 mg/dL (ADA) / <92 mg/dL (IADPSG)
1-hr post-prandial	<140 mg/dL
2-hr post-prandial	<120 mg/dL
HbA1c	<6.0% (non-hypoglycemic)

Why stricter targets? Even mildly elevated blood glucose (above normal) causes macrosomia and perinatal complications. Unlike in non-pregnant adults, the threshold for harm is lower in pregnancy because the fetus is directly exposed.

3. Maternal Complications of Diabetes in Pregnancy

Complication	Notes
Pre-eclampsia	3-4x higher risk (GDM), even higher with pre-gestational DM + nephropathy
Polyhydramnios	Fetal polyuria → excess amniotic fluid
Preterm labor	Overdistension from polyhydramnios
Recurrent UTI / candidiasis	Glycosuria provides growth medium
DKA (diabetic ketoacidosis)	More likely in T1DM, can occur at lower blood glucose than in non-pregnant
Operative delivery	Higher LSCS rate (macrosomia, failed induction)
PPH	Overdistended uterus (polyhydramnios, macrosomia) → poor uterine tone
Worsening retinopathy	Rapid improvement of glycemic control paradoxically can worsen
Nephropathy progression	Increased GFR in pregnancy can worsen proteinuria
Future T2DM (50-70% risk)	5-10 years after GDM

4. Fetal / Neonatal Complications

Complication	Notes
Macrosomia	BW >4 kg or EFW >90th centile
Shoulder dystocia	Asymmetric macrosomia - large shoulders, normal head
Birth asphyxia	Shoulder dystocia, prolonged labor, large baby
Neonatal hypoglycemia	<47 mg/dL in term neonate, <40 mg/dL preterm
RDS	Delayed surfactant maturity (insulin inhibits surfactant)
Polycythemia / Jaundice	Hematocrit >65%, severe neonatal jaundice
Hypocalcemia, Hypomagnesemia	Neonatal metabolic complications
Congenital malformations	3-4x higher in pre-gestational DM
Perinatal mortality	4-5x higher in poorly controlled pre-gestational DM

5. Management of Corticosteroid-Induced Hyperglycemia

When betamethasone (for lung maturity) is given at 24-34 weeks:

Blood glucose rises significantly 6-48 hrs after injection
Insulin doses need to be increased by 25-40% during this period
Monitor blood glucose every 4-6 hours after steroid injection
Return to previous regimen after 48-72 hours

PART 8 - INVESTIGATIONS AND MANAGEMENT

Investigations

Screening and Diagnostic:

GCT (Glucose Challenge Test): 50g oral glucose, non-fasting, 1-hr venous glucose
- Cut-off: ≥140 mg/dL = screen positive → proceed to OGTT
- India DIPSI: 75g non-fasting, 2-hr → ≥140 = GDM (single-step)
75g OGTT (IADPSG): at 24-28 weeks (or at first visit if high risk)
HbA1c: At booking (if ≥6.5% before 20 weeks = overt pre-gestational DM)
Fasting blood glucose + 2-hr PPBS: For monitoring
Urine for glucose and ketones: Every visit

For Complications Assessment:

CBC, RFT, LFT, urine microalbumin (pre-gestational DM)
ECG, echocardiography (long-standing pre-gestational DM)
TSH (associated autoimmune thyroid disease in T1DM)
Fundoscopy (diabetic retinopathy)
Urine culture (recurrent UTI)

Fetal Assessment:

Anomaly scan (18-20 weeks): Congenital malformations (cardiac, NTD, caudal regression)
Fetal echocardiography (22-24 weeks): Cardiac defects
Growth scan every 4 weeks from 28 weeks: EFW, AC
AFI: Polyhydramnios monitoring
Umbilical artery Doppler: If IUGR (vascular DM)
CTG from 36 weeks: Twice weekly
BPP from 32 weeks

Management

A. Pre-conception Counseling (Pre-gestational DM):

Achieve HbA1c <6.5% before conception
Stop teratogenic medications (ACE inhibitors, statins, ARBs)
Start folic acid 5 mg/day (high-dose, due to increased NTD risk)
Treat retinopathy / nephropathy before pregnancy
Assess cardiovascular status
Switch to insulin from oral agents if not already on insulin

B. Diet and Lifestyle (All GDM - First Line):

Carbohydrate restriction: 35-45% of total calories from complex carbs
3 main meals + 3 snacks per day (prevents large glucose swings)
Avoid simple sugars, refined carbs, sugary drinks
Physical activity: 30 min moderate exercise/day (reduces insulin resistance)
Target weight gain: GDM - 11-16 kg (normal BMI); 7-11 kg (overweight); 5-9 kg (obese)

C. Monitoring (Self-Blood Glucose Monitoring - SBGM):

Fasting + 2-hr post each meal = 4 readings/day
Targets: Fasting <95 mg/dL, 2-hr PP <120 mg/dL

D. Pharmacological Treatment:

When to start insulin:

Fasting glucose ≥95 mg/dL OR 2-hr PP ≥120 mg/dL, despite 1-2 weeks of dietary control
Any HbA1c ≥6% in GDM (reflects persistent hyperglycemia)

Insulin regimens in pregnancy:

Basal-bolus regimen (most physiological):
- Basal: NPH insulin at bedtime (or long-acting: detemir/glargine - detemir preferred)
- Bolus: Short-acting (regular) or rapid-acting (aspart/lispro) before each meal
Starting dose: 0.7-1.0 units/kg/day (total), divided as 2/3 morning, 1/3 evening
Adjust weekly based on SBGM readings

Oral agents in pregnancy:

Metformin: Used in some centers (crosses placenta, long-term data limited) - not approved FDA in pregnancy but used in T2DM/GDM in many countries; may be used if insulin refused
Glibenclamide (Glyburide): Largely abandoned (fetal hypoglycemia risk)
NOT RECOMMENDED: All other OHAs (glipizide, DPP4i, SGLT2i, GLP1 agonists) - insufficient safety data

E. Timing and Mode of Delivery:

Situation	Timing	Mode
GDM on diet alone, well-controlled, no macrosomia	40-41 weeks	Vaginal / IOL
GDM on insulin, well-controlled, no complications	38-39 weeks	IOL or vaginal
GDM, macrosomia (EFW >4.5 kg)	38 weeks	Consider LSCS
Pre-gestational DM, well-controlled	38-39 weeks	IOL
Pre-gestational DM, vascular complications	36-37 weeks	LSCS
DKA, fetal compromise	Urgent	LSCS

Intrapartum glucose management:

Target blood glucose: 80-110 mg/dL during labor
IV glucose + insulin infusion (GKI - glucose-potassium-insulin drip)
Check blood glucose hourly
Stop long-acting insulin on day of delivery

F. Postpartum:

GDM: Stop insulin immediately after delivery in most cases
Check fasting blood glucose at 6 weeks postpartum (75g OGTT)
50-70% risk of developing T2DM in 5-10 years - lifestyle counseling
Breastfeeding encouraged (reduces maternal T2DM risk and obesity in offspring)
Contraception: COC may worsen glucose tolerance; progesterone-only or barrier preferred

PART 9 - VIVA QUESTIONS AND ANSWERS

Q1. Define GDM. How is it diagnosed in India? A: GDM is glucose intolerance first detected during pregnancy, regardless of whether it persists postpartum. In India, the DIPSI (Diabetes in Pregnancy Study Group India) protocol is widely used: a non-fasting 75g oral glucose load is given, and 2-hour venous plasma glucose ≥140 mg/dL is diagnostic of GDM. This single-step, non-fasting approach is practical for Indian healthcare settings. IADPSG criteria (fasting 75g OGTT at 24-28 weeks) uses cut-offs of fasting ≥92, 1-hr ≥180, or 2-hr ≥153 mg/dL (any one value).

Q2. What is the most diabetogenic hormone of pregnancy? A: Human Placental Lactogen (hPL), also called human chorionic somatomammotropin. It increases with placental size, peaking in the third trimester. It is the primary cause of progressive insulin resistance. Other counter-regulatory hormones contributing: progesterone, cortisol, prolactin, and estrogen. This explains why insulin requirements increase throughout pregnancy and why GDM typically manifests at 24-28 weeks (when hPL levels peak).

Q3. What is the significance of macrosomia in a diabetic pregnancy? A: Macrosomia (birth weight >4 kg or EFW >90th percentile) results from fetal hyperinsulinism due to maternal hyperglycemia. It causes: shoulder dystocia (asymmetric - large shoulders, normal head → trapped behind pubic symphysis), birth trauma (brachial plexus injury, clavicle fracture), failed vaginal delivery/LSCS, birth asphyxia, neonatal hypoglycemia (hyperinsulinism persists after birth), polycythemia, and jaundice. Diagnosis by USG: abdominal circumference (AC) >90th centile is the earliest and most sensitive marker.

Q4. What is caudal regression syndrome? Why is it associated with DM? A: Caudal regression syndrome (sacral agenesis) is a rare congenital anomaly characterized by absence or hypoplasia of the sacrum and lower lumbar vertebrae, leading to lower limb deformities. It is 200-400 times more common in infants of diabetic mothers and is considered pathognomonic of diabetic embryopathy. The mechanism involves hyperglycemia impairing development of the caudal mesoderm during the 3rd-7th week of embryogenesis. HbA1c >10% in early pregnancy significantly increases risk.

Q5. Why does neonatal hypoglycemia occur in infants of diabetic mothers? A: During pregnancy, fetal blood glucose tracks maternal glucose. Fetal hyperglycemia stimulates fetal pancreatic beta cells to produce excess insulin (hyperinsulinism). After birth, the maternal glucose supply abruptly stops, but the fetal/neonatal hyperinsulinism persists for hours to days. The excess insulin causes rapid glucose uptake and inhibits gluconeogenesis → neonatal hypoglycemia (blood glucose <47 mg/dL). This typically occurs within 1-4 hours of birth. Prevention: good glycemic control in labor; early feeding or IV glucose in neonate.

Q6. Why does insulin cause delayed lung maturity in diabetic pregnancy? A: Cortisol is the key hormone that stimulates surfactant synthesis by type II pneumocytes. Insulin is a functional cortisol antagonist - it suppresses cortisol-mediated induction of surfactant phospholipid synthesis. In a fetus with hyperinsulinism (from diabetic mother), this suppression delays maturation of surfactant, increasing the risk of Respiratory Distress Syndrome (RDS/HMD). This is why the lecithin-sphingomyelin (L:S) ratio may be falsely reassuring in diabetic pregnancies - phosphatidylglycerol is a better marker of lung maturity in diabetic pregnancies.

Q7. Is metformin safe in pregnancy? A: Metformin crosses the placenta and reaches the fetus. Long-term follow-up data (TOFU study) suggests children exposed to metformin in utero have higher rates of obesity at 9-18 years. Current guidelines: metformin may be used as an alternative in T2DM/GDM when insulin is not available or refused (some NICE and ACOG guidance), but insulin remains the preferred agent. Metformin is NOT teratogenic but its long-term fetal metabolic effects are a concern. ACE inhibitors, ARBs, and statins are absolutely contraindicated.

Q8. What are the blood glucose targets during labor in a diabetic woman? A: Target blood glucose during labor: 80-110 mg/dL. This is important because: maternal hyperglycemia during labor → fetal hyperglycemia → fetal hyperinsulinism → severe neonatal hypoglycemia immediately after birth. Method: GKI (Glucose-Potassium-Insulin) infusion or insulin infusion with separate IV glucose. Monitor blood glucose every 1-2 hours. After delivery, insulin requirements drop sharply (placenta - the source of counter-regulatory hormones - is delivered).

Q9. What is the postpartum management of GDM? A: (1) Stop insulin immediately after delivery in GDM (requirements drop dramatically). (2) Perform 75g OGTT at 6 weeks postpartum to diagnose persistent T2DM. (3) Counsel on 50-70% lifetime risk of T2DM. (4) Lifestyle modification: weight loss, exercise, healthy diet reduces T2DM risk by 50%. (5) Annual fasting glucose or HbA1c for life. (6) Screen future pregnancies early for GDM (recurrence rate 30-50%). (7) Encourage breastfeeding - reduces maternal obesity and infant obesity risk.

Q10. What is diabetic ketoacidosis (DKA) in pregnancy? Why is it dangerous? A: DKA can occur at lower blood glucose levels in pregnancy (euglycemic DKA at 200-250 mg/dL vs 300+ in non-pregnant). Precipitants: infection, hyperemesis, steroid administration, insulin pump failure. Maternal acidosis causes fetal acidosis + uterine vasoconstriction → fetal death risk is very high (15-30% fetal mortality). Management: aggressive IV fluid replacement, insulin infusion, potassium replacement, treat precipitant. DKA in pregnancy is an obstetric emergency.

Q11. What advice will you give a woman with GDM for future pregnancies? A: (1) Undergo pre-conception optimization: achieve ideal body weight, HbA1c <6.5% before next conception. (2) Screen for T2DM before next pregnancy. (3) Book early in next pregnancy and screen for GDM at first visit (not at 24-28 weeks as for general population). (4) Take high-dose folic acid (5 mg) periconceptionally. (5) Inform that GDM recurrence risk is 30-50%. (6) Lifelong lifestyle modification reduces risk of recurrence and future T2DM.

Q12. What is White's classification of diabetes in pregnancy? A: White's classification (Priscilla White, 1949) stratifies diabetes by severity:

Class A1: Diet-controlled GDM
Class A2: Insulin-requiring GDM
Class B: Onset ≥20 years, duration <10 years, no vascular disease
Class C: Onset 10-19 years or duration 10-19 years
Class D: Onset <10 years or duration >20 years or background retinopathy/hypertension
Class F: Nephropathy (proteinuria >500 mg/day)
Class R: Proliferative retinopathy
Class H: Heart disease Higher classes have worse maternal and fetal outcomes.

Ready for the Next Case!

That completes Long Case 4: Diabetes Complicating Pregnancy.

Say "next" for Long Case 5: Multiple Pregnancy (Twins).

Finding Sources

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

This is a shared conversation. Sign in to Orris to start your own chat.